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Abstract
Increasing competition and specialization of firms in the life sciences industry has led to
recognition of the need for collaboration. Bioclusters, the co-location of life sciences
entities in a specific geographic area, have therefore emerged as a global trend. While it
is assumed that such clusters allow stakeholders to realize synergies through participation
and presence in the local area, the collaborative behavior within these clusters has yet to
be explored.
The goal of this study was to characterize the barriers and enablers of effective
collaboration within bioclusters, and amongst their key stakeholder groups. This study
directly compared the bioclusters of San Diego and Singapore to gain an understanding
of their relative collaborative environments. San Diego, with cluster longevity of over 40
years, provided an example of organic growth, given its roots in entrepreneurial
activities. The Singapore cluster, still in an embryonic state, has a history of organized
growth due to the leadership, support, and funding of the Singaporean government. The
study of clusters that differ in history of formation and longevity of presence provided the
breadth of information needed for an effective comparison of their collaborative
environments and approach to collaborative endeavors.
Key stakeholder groups, namely academia, industry, finance, and government, were
identified and interviews within each cluster were targeted accordingly. Eighteen
interviews were conducted in San Diego and sixteen in Singapore. Through literature
review, design of a detailed questionnaire, completion of 34 interviews, and analysis of
the resulting data, an empirical assessment of the environment for collaboration within
each biocluster was performed. Use of two scoring models provided an objective relative
comparison of the clusters, serving as tools to view aggregated interview results. The
first model measured the environment for and level of local collaboration and resulted in
a Collaboration Score. The second model compared the process of engagement in
collaborative endeavors, and resulted in a Formality of Approach Score. The scoring
models were also used to compare the collaborative behavior of key stakeholder groups.
Results from relative scoring models indicated a higher Collaboration Score for
Singapore as compared to San Diego (p-value=0.0421), and a higher Formality of
Approach Score for San Diego, trending toward significance. Aggregate analysis of key
stakeholder groups found finance as the most collaborative, with a higher Collaboration
Score when compared to industry, the least collaborative group (p-value=0.0189). A
higher Formality of Approach Score was also seen for finance when compared to
academia (p-value=0.0479). Other notable results include a greater degree of local
competition within San Diego (p-value=0.0266) and a particularly low percentage of
local industry collaborations in both bioclusters, when compared to academia (p-
value=0.0002).
The enablers of collaboration in the San Diego biocluster were identified as the
entrepreneurial culture and the existence of top research institutes, and barriers were
found to be the high level of competition amongst cluster members and the lack of local
venture capital presence.
The enablers in the Singapore biocluster were identified as the physical co-location of
public and private entities in the Biopolis and the leadership and financial support
provided by the Singaporean government, and barriers were the culture of risk aversion
that exists in the cluster and the relatively few entrepreneurs, who often serve as a
backbone for the creation of informal networks.
A model for the development of a biocluster was also identified through a comparison of
the cluster formation history of San Diego and Singapore. This model needs to be refined
and further tested for general applicability, but does suggest a promising start.
Collaborations are important for the continued cycle of innovation in the field of life
sciences. Bioclusters provide a forum for these collaborations to occur. Promoting the
enablers and removing the barriers increases the effectiveness of collaborations,
enhancing the success of a biocluster and its member firms.
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Introduction
Genesis of Project
This project was initiated as a result of an indicated interest by both the MIT
Center for Biomedical Innovation (CBI) and the Ewing Marion Kauffman Foundation.
The broader topic of Research and Development productivity within the life sciences
industry and the role that collaborations play in enhancing this productivity was
discussed, specifically as it relates to a fairly new concept that has materialized as a
global trend - bioclusters. It was at the intersection of these two topics, namely
collaborations and bioclusters, that the genesis for an in-depth study emerged.
With increasing global competition and specialization of firms, the life sciences
industry is slowly recognizing the need for collaboration along all aspects of the value
chain and product lifecycle. Bioclusters are a natural byproduct of this recognition,
resulting in the co-location of entities interested in achieving synergies via participation
and presence in areas where key stakeholders and support infrastructure are already
present.
Definition of Biocluster
The concept of industrial clusters has recently become a popular topic of
discussion for both academia and industry. Simply defined, a cluster refers to a large
group of firms in related industries at a particular location (Swann and Prevezer 1998).
These industry clusters are geographic concentrations of sometimes competing,
sometimes collaborating firms, and their related supplier network (DeVol et al 2004).
Some have even defined the cluster as a self-reinforcing community of institutions,
including universities, corporations, and government agencies (Mayer 2007). With so
many differing definitions and related concepts, it is important to clarify two questions:
What specifically is a biocluster and how does one define its boundaries?
A study conducted by the Milken Institute defines a cluster as representative of an
entire value chain of a broadly defined industry sector from suppliers to end products,
including its specialized infrastructure (DeVol et al 2004). For the purposes of this study,
I further expand upon this definition to adapt it to the life sciences industry, and identify
some boundaries by pictorially representing such a cluster, as seen in Figure 1. I define a
biocluster as a geographic concentration of entities who in some way contribute to and
enable this product development life cycle. Support firms are inclusive of all of the
functions that need to be present for the cluster to exist. This includes stakeholders such
as a robust financial investment community, legal services, accounting firms, and
government entities.
Support Functions
] - -,,-i . . . .. .... . ]
Figure 1. Pictorial representation of the general product development process within the life sciences
industry. Those involved in enabling, supporting, or contributing to this process are considered to be a part
of the biocluster. The support functions include entities such as government, finance, and legal services.
As a cluster develops and matures, additional service functions often emerge to fulfill the
needs of surrounding firms. For example, contract research organizations (CRO's) or
fee-for-service animal testing facilities might come into existence as companies or
academic institutions move from basic research into the development and clinical trial
phases. Additionally, trade organizations that promote networking and collaboration
within the cluster become increasingly important, as they often provide group purchasing
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policies and training opportunities for professionals within the industry. Academic
institutions in the area may begin to see increased demand for specialized coursework in
the biotechnology or health care fields, and as a result adapt their course offerings to fill
these needs. Over time, the existence of a biocluster in a specific geographic area can
therefore have a profound effect on the growth and development of the surrounding
infrastructure as well; this may account for the heavy investments in mimicking this
concept on a global level.
Rapid Expansion of Bioclusters: A "Me-Too" Phenomenon?
Many cities across the Unites States are beginning to embrace the concept of
developing their own biocluster, having seen the success experienced by those already in
existence. Numerous areas have recently invested heavily in this concept, namely
Raleigh-Durham, San Francisco, and perhaps a more surprising entry, New York City.
Mayor Michael Bloomberg of NY announced in 2005 the development of the East River
Science Park, a $700 million, privately financed, 870,000 square-foot facility that will
provide healthcare laboratory space on the campus of Bellevue Hospital Center (Mayer
2007). Ranking second in funding from the National Institutes of Health (NIH) from
1999 to 2004, and ranked first in the total number of biotechnology-related patents issued
over the last decade, NY is now making a significant effort to enter and coordinate their
efforts in this field (Mayer 2007). Internationally, there has been a push as well, with
prime examples being Singapore and Israel. Many of the trade conventions and industry
conferences now have sessions dedicated to this concept, as well as exhibition floors
filled with countries marketing their own version of the biocluster, and what flavor
thereof their country could offer. Has this become a "me-too" phenomenon? Perhaps it
has, but the real question is: what does it take to succeed and does your city or country
have the necessary key ingredients?
There have been efforts more recently to characterize this concept, namely the
identification of the key ingredients to build a biocluster. The best source of information
is, of course, the bioclusters that are currently in existence, and an understanding of what
enabled them to form. Swann and Prevezer, among others, have studied this extensively
and cite the initial conditions necessary for a biocluster to develop as: 1) the existence of
a strong science base, 2) the presence of experienced financing mechanisms, and most
importantly, 3) the ability to create and sustain fluid networks, whereby information
about new opportunities and technologies can travel swiftly within the community
(Swann and Prevezer 1998). While capital investment on behalf of a city/country may in
fact enable the first two conditions to exist, the latter condition indicates a need for an
ingredient less tangible and accessible. Simply interpreted, the culture for innovation and
collaboration must be present in order for a biocluster to successfully develop.
After it has been established that the key ingredients necessary for the formation
of a biocluster exist, the next step towards developing a cluster is attracting the various
stakeholders to join. This requires an understanding of why they might be inclined to do
so. Literature on clustering of biotech firms points to two themes that help explain the
desire to co-locate (Schweitzer 2004). The first is that there are natural factors that draw
particular firms to particular areas (Marshall 1920). These factors might include natural
resources, ease of transportation, or location of supply or product markets (Schweitzer
2004). The second theme is that firms are interested in achieving synergies and therefore
are attracted to "economies of agglomeration" (Gries, Dibner, and Bean 1995). Such
synergies might be related to human capital or labor market offerings, the need to reduce
consumer search costs, or lastly the desire of firms to cooperate, perhaps even vertically
or horizontally integrate, to raise product quality (Schweitzer 2004). The collaboration
insinuated in the latter theme enables the small and medium sized firms to compete on a
global level with much larger firms (Schweitzer 2004). However, in an age where
communication and connection to individuals is so easily enabled by the internet, one
wonders if these firms benefit at all from physical clustering (Stiglitz 1999). Perhaps the
draw is participation in a geographic brand message, a prime example of which would be
the Silicon Valley era. High-tech startups received an automatic mental stamp of
approval, in large part given their location in Silicon Valley and the brand message that it
sent.
Therefore, why do we still see these industrial clusters occurring, now more
popular in the life sciences space, and do the firms actually collaborate within the cluster
or are they just co-located for the purposes of branding, and thereby just co-exist? In an
attempt to answer these questions and others, this study was therefore initiated.
Study Design
This study was designed to be the first part of a larger endeavor to understand the
role that geographic bioclusters play in increasing collaboration amongst its key
stakeholders. The ultimate goal of the larger endeavor is to define a best practice model
for enhancing productivity through effective collaborations within a biocluster.
This first phase of research called for an understanding of the barriers and
enablers of effective collaboration within bioclusters, and amongst their key stakeholder
groups. The outlined approach to achieve this goal is shown in Figure 2.
The literature search was an important element, as an understanding of prior work
in this area allowed for the identification of key aspects one should take into
consideration when studying bioclusters. However, it should be noted that while industry
clusters have been well characterized and studied, bioclusters are still a fairly new topic,
and literature regarding this topic is sparse. Therefore, a review of the methodologies
that have already been used to conduct detailed analyses of industry clusters was
important for the development of study design. Lastly, the literature search provided an
understanding of the existing bioclusters and their respective histories of development.
The questionnaire design provided an opportunity to address limitations of current studies
and the identification of information that would be necessary to understand the barriers
and enablers of collaboration, for the purposes of my end goal. Perhaps the most
important piece was the identification of interviewees, as the data collected would only
be as valuable and accurate as the sources from which they were derived. Both
questionnaire design and interviewee selection are discussed in further detail in the
Methodology section of this thesis.
Community information gathering was the third phase of the project, requiring
face-to-face interviews with individuals in each of the bioclusters of interest. This was
the data collection phase, with the primary goals of gaining an in-depth understanding of
the barriers and enablers for collaboration, observing the "cluster in action" by speaking
with the individuals actively engaged in collaborative endeavors, touring the various
facilities and firms that are key footholds to their respective clusters, and gaining a feel
for the cluster culture through observations and conversations. The interview process is
discussed in the Methodology section of this paper.
S Literature Search
....... ..... . . . .. .. . .... ... ... ....... .. . ......
Questionnaire Design
and
Identification of Interviewees .
Community Information
Gathering
...... '''"" ... ..........................  .. . ..... ....... ....... .
Analysis and Discussion
of
Interview Results
Review of articles and texts serves as a basis for current
facts regarding the bioclusters of interest, as well as provide
an understanding of previous methodologies used to
evaluate geographic clusters.
Design and test a questionnaire that will provide a baseline
for analysis amongst the biolcusters, particularly focusing
on areas where current literature falls short. Interviewee
identatcation would be key to ensuring valuable and robust
data voints.
Through face-to-face interviews, understand from the key
stakeholders within chosen bioclusters what the barriers
and enablers of collaboration are within their biocluster, and
how extensively they currently use their surrounding
biocluster for collaborative endeavors.
By analyzing bioclusters with varied maturity and history of
formation, we can compare and contrast the various
barriers and enablers to collaboration that exist and
determine which are lead indicators of success or failure of
collaborative endeavors.
Figure 2. Outlined approach for achieving project goal of characterization of the barriers and enablers of
effective collaboration within bioclusters. Four phases of project were identified, namely literature search,
questionnaire design and interviewee identification, community information gathering, and analysis of
interview results.
Lastly, the analysis of interview results enabled me to objectively compare and
contrast the bioclusters of interest, based on the information obtained through the
interview process. My observations and additional conversations, in combination with
this data, provided the basis for informed conclusions to be drawn. The data analysis
process is also described in the Methodology section of this paper.
Selection of Bioclusters
After careful consideration, bioclusters were selected on the basis of variation
among two key aspects:
1. Longevity of Cluster Presence (mature vs. new)
2. History of Formation (spontaneous vs. planned)
"l'"l'f " f ""1 " I" 1"1"1"" f..................................................................................................................
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Clusters that have been in existence for a varying degree of time were first considered,
and then evaluated along the second point, regarding the way in which they were formed.
Three bioclusters were eventually chosen for the purposes of the study, namely Boston,
San Diego, and Singapore. Boston provided an example of a mature cluster that formed
in a spontaneous manner, or via organic growth (see Figure 3). San Diego is a cluster
that has been in existence for approximately 40 years, therefore falling in between new
and mature, and was semi-planned. Many refer to its formation as one of a process of
"nucleation". Lastly, Singapore is a brand new biocluster, and one that has been
completely planned from the start: a true product of organized growth.
Additionally the selection of these three bioclusters was of extreme interest as I
had not yet come across any published work which studied the biocluster in Singapore.
Various news pieces and articles have spoken of the heavy investments by the
Singaporean government in the development of this cluster, but no one had yet compared
it to a biocluster in the United States.
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Figure 3. The chosen bioclusters of Singapore, San Diego, and Boston are shown above,
specifically as they relate to the two selection factors of history of formation and longevity of
cluster presence.
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Studying bioclusters that differ among these two aspects allows for an additional element
of interest to be included for future work, namely a potential correlation of the way in
which cluster maturity and formation history affect eventual success of the cluster. More
importantly, however, for the end goal of the larger project, studying bioclusters that vary
along these two dimensions provides the breadth of information needed to build a
universally-applicable best practices model.
Identification of Key Stakeholders
A study by the Milken Institute highlighted the need for presence of strong
research universities and institutes, industry entrepreneurs as well as giants, human
capital and workforce talent, financial investment entities and support infrastructure as
being necessary key ingredients of a biocluster (DeVol et al 2004). I used this
information to provide further structure to my interview plan, by delineating key
stakeholders of interest, as seen in Figure 4.
Acaemi Ius
> Professors actively
involved in collaborative
efforts
> Technology licensing
offices of universities
> Large companies
Head of Research, HR, BD
> Medium-sized companies
Head of Research
> Start-ups
CEO, COO
Go ernmentFinancia l Suppor
> Individuals involved with
establishing economic
and public policies that
affect biocluster
> Venture capital firms
SAngel investors
Figure 4. Interviews targeted at key stakeholders, within the areas of academia, industry, government, and
finance, would enable a better understanding of the extent of the collaborative environment within each of
the bioclusters of interest.
•, 
Venture 
capital 
firms
Angel 
investors
Additional identification of individuals within each of these four key areas was then
pursued, also seen in Figure 4, to ensure that I would be meeting with those most actively
involved in collaborative endeavors.
The narrowing of interviewee targets to specific profiles and roles, within each
stakeholder group, was initially difficult, as collaborative endeavors are shared among
various roles in an organization. Therefore, the questionnaire was designed first, so as to
understand the type of information I would need to elicit from those with whom I met,
and then target profiles were identified accordingly. As the desired interviewee would
need to have knowledge of all key aspects of the questionnaire, namely productivity,
human capital, infrastructure, and cluster culture, it was then possible to further focus the
target profiles on those who would be able to inform these areas.
The first group, academia, includes research institutes that are engaged in basic
research. A recent article on advancing innovation highlights that the most important
relationship between academia and industry is often considered to be the patent-and-
license model, in which industry bids on intellectual property that can be turned into
products, or are enabling technologies for finding products. However, recent studies
suggest that if the overall goal is the transfer of knowledge from universities into
industry, then it is the research faculty themselves that are the key agents of knowledge
transfer (Mitchell 2007). Therefore, when identifying individuals who would be ideal to
interview for this project, I chose to meet with active collaborators within academia as
well as the technology licensing offices of universities, to ensure that the information
obtained was an accurate representation of the collaborations between academia and
industry. In addition, directors of research institutes who also fit this profile were of
interest.
The industry stakeholder group is fairly broad in range, as input from a cross-
section of large, medium, and small firms is desired. Large companies are characterized
as those with a market capitalization of over $5 Billion (USD), small companies as those
less than $1 Billion, and medium sized firms as those that fall in between. As large firms
are often fairly segregated with regard to functional roles, meeting with two or more
individuals from one firm is perhaps needed to fill the various aspects of the
questionnaire.
The government stakeholder group was mainly established with recognition that
the government in Singapore plays an active role in the development of the biocluster,
and therefore needed to be an integral component of the study. In the US-based
bioclusters, this is not as important as the government has little, if any, involvement with
regards to collaborative endeavors within these clusters.
The last stakeholder group, namely Financial Support, was narrowed to focus on
the venture capital and angel investor community because of the unique role they play in
enabling transfer of ideas from academia to life sciences companies. In the US, funding
during the basic research phase of the product lifecycle often comes from governmental
grants, such as the National Institutes of Health (NIH) and the National Science
Foundation (NSF). Small companies in the initial start-up phase are also able to obtain
funding through Small Business Innovation Research (SBIR) grants. The translation of
basic research into the development phase, often where venture capitalists and angel
investors enter the picture, are where we most often see collaborative endeavors. The
latter phases of the product development lifecycle are then funded by industry or via
public markets. Therefore, for the purposes of this study, I chose to focus specifically on
the perspectives of the venture capitalists and angel investors.
An additional stakeholder group that was not specifically targeted for interviews,
but considered to have valuable input with regards to collaborations within the clusters,
was industry trade associations, and this was kept in mind during the networking and
interviewee selection process.
Thesis Objective
As discussed earlier, this thesis is part of a larger study which I have undertaken
in conjunction with the MIT Center for Biomedical Innovation and the Ewing Marion
Kauffman Foundation.
This particular thesis is solely focused on the characterization of the barriers and
enablers of effective collaboration within the bioclusters of Singapore and San Diego.
The four step process outlined in Figure 2 of the Study Design section of this paper,
namely literature search, questionnaire design and identification of interviewees,
community information gathering, and analysis and discussion of interview results,
constitutes this thesis project, as it relates to the Singapore and San Diego bioclusters.
The specific goals of this thesis project are to do the following:
* Characterize the barriers and enablers of effective collaboration within the
bioclusters of San Diego and Singapore.
* Empirically assess the following hypotheses:
o The lack of institutional barriers in Singapore, given the strong
governmental presence through funding and leadership of the biocluster,
will prove to be an enabler for collaboration. This will result in a higher
percentage of local collaborations for Singapore, when compared to San
Diego, and a more collegial and collaborative environment.
o The differences in cluster structure, namely organized (top-down) for
Singapore and organic (bottoms-up) for San Diego, is a clear distinction
that will be reflected in the increased formality of the process by which
collaborative endeavors are engaged in Singapore.
o Heavy capital investment, as seen in Singapore, is a necessary but not
sufficient enabler for the creation of the truly collaborative biocluster. I
expect to find that the abundance of funding in Singapore in fact has the
opposite effect, becoming a barrier by decreasing the need to collaborate.
In addition, I hope to lay the foundation for follow-on work to be pursued in this area. A
study directly comparing the Singapore biocluster to that of a US city has not yet been
completed, to the best of my knowledge, and I therefore hope to provide the scientific
and business communities with a valuable perspective through such an effort.
Historical Background on Bioclusters of Interest
The San Diego and Singapore bioclusters were specifically chosen for this
analysis since they differ on the two aspects highlighted earlier, namely maturity and
formation. In studying and characterizing their current collaboration environments, it is
helpful to understand how these clusters compare with regard to the two selection factors.
This is best related via a review of their historical backgrounds.
San Diego Biocluster History
San Diego has its roots in over a century of academic and military research,
whose strong foundation has brought both scientific and financial prosperity to the area
(Veltman 2003). San Diego's efforts to build a science and technology hub began in the
1950's when city officials designated an area called the Torrey Pines Mesa as a science
and technology zone. Only high-tech organizations were allowed to build there, the first
inhabitant of which was a defense company General Atomics (GA). This company went
on to spawn over 60 different science companies, including Sharp Laboratories and
Science Applications International Corporation (SAIC) (Veltman 2003). This was the
first of many examples of the "nucleation" process by which San Diego has grown.
Establishing a Foundation in Basic Research
The defense industry was booming after World War II, and with the resulting
influx of capital the city was ready to diversify its industry focus into the sciences. An
early catalyst for biomedical research activity in the region was The Scripps Research
Institute (TSRI), founded in 1955 as the Scripps Clinic and Research Foundation (DeVol
et al 2004). Next, a new campus of the University of California, namely UCSD, was
opened in 1960 and focused solely on science and engineering programs. This was
followed closely by the building of the now world-renowned Salk Institute and later the
Burnham Institute (Veltman 2003). These four basic research entities, namely TSRI,
UCSD, and the Salk and Burnham institutes, serve as the pillars for life sciences research
in San Diego, the evolution of which is illustrated in Figure 5.
These basic research pillars have proven to be a large source of successful
technology transfer. There are 120 local companies with UCSD technology. TSRI has
been the impetus behind 40 companies, and the Salk Institute has spawned 18 companies
since the late 1980's. As of early 2005, The Burnham Institute had four FDA-approved
products with an additional seven in clinical trials (US-EU Innovation Summit 2005).
Other research centers in the area include the Sidney Kimmel Cancer Center,
Neuroscience Research Institute and the La Jolla Institute of Allergy and Immunology.
Together, the basic research entities in San Diego spend $1 + billion per year on
biomedical research (Panetta 2003).
Figure 5. The timeline above shows the evolution of life science research in the area, specifically
the four pillars of the San Diego basic research community. Source: San Diego: Eco-System for
Innovation, US-EU Innovation Summit.
Entrepreneurship drives cluster growth
However, what is most often credited as being the catalyst of growth for the life
sciences cluster in San Diego is the biotech company, Hybritech. Founded in 1978, this
monoclonal antibody-based diagnostic company is known for the development of the
rapid visual pregnancy test and the prostate-specific antigen (PSA) test (Eastham 2007).
Within five years of Hybritech's founding, spin-off companies began to emerge, a trend
that accelerated over time, as can be seen in Figure 6. As of the 2 5th anniversary of
Hybritech's founding, the San Diego Union Tribune counted more than 50 firms that
could be considered the progeny of San Diego's original biotech firm (DeVol et al 2004).
Hybritech itself was acquired by Eli Lilly for $480 million in 1986, but it left a lasting
effect via the talent pool of Hybritech alumni, who moved on to new enterprises and
initiatives (DeVol et al 2004).
Cluster Development:
Anchor Companies and Spin-Offs in San Diego
Figure 6. As one of America's pioneer biotech companies, Hybritech gave rise to over 50 other
startup companies, some of which are shown here, thereby serving as one of the catalysts of San
Diego's life science cluster development. Source: Burnham Institute of Medical Research, 2007
San Diego's dependence on the defense industry slowly lost its foothold in the
early 1990's, with a loss of 58,000 jobs in the region due to defense budget cuts.
Unemployment rose to 8.4% in the region by July 1993, and the city had to diversify its
industry base by moving with more direction into synergistic fields, such as life sciences
and wireless communications (Veltman 2003). This provided yet another push in the
direction of life sciences, simultaneously providing available, talented human capital.
Cluster Gains Momentum
While San Diego's basic research and entrepreneurial communities have been
maturing, they have slowly attracted other industry players to the region. Larger
pharmaceutical companies, such as Pfizer, Novartis, Merck, and Johnson and Johnson
have joined the approximately 400 start-up biotech companies in the area, while
international players are also committing to future development there (Panetta 2003).
The Torrey Pines Mesa is now inhabited by a variety of firms, and the cluster has spread
to the surrounding area. The support infrastructure has correspondingly matured, with
the emergence of many real estate developers, lawyers, accountants, and marketing firms,
making it a convenient place to start a company. Attracting $1.5 billion in venture capital
investment from 1995-2001 and having issued 1,875 biotech patents from 1975-1999, the
San Diego life sciences cluster is now known as one of America's biotech hotbeds
(Panetta 2003).
The cluster has also had an enormous impact on the surrounding community,
employing more than 33,415 people in 2004. In fact, its biotechnology employment is
2.4% of the US industry total, however San Diego county only has 1% of the US
population (Bergman 2006). A majority of these individuals (65%) work in research
services, with another 12% in pharmaceuticals and related manufacturing (Bergman
2006).
Therefore, with a history dating back approximately 40 years, the formation of the
San Diego biocluster is best described as a semi-planned process, through the designation
of the Torrey Pines Mesa and formation of world-renown research entities, such as
UCSD, Salk, Burnham, and Scripps. The cluster has grown via "nucleation" of firms
such a Hybritech, which has spawned over 50 companies and greatly contributes to the
entrepreneurial culture that dominates the region. As it continues to mature, San Diego
has built a strong foundation and reputation in the field of life sciences, specifically
biotechnology, attracting large industry players to the area and developing a sophisticated
support infrastructure.
Singapore Biocluster History
Forty years is significant in the history of Singapore as well, as it represents the
amount of time that Singapore has existed as an independent country. Having received
independence in 1965, Singapore has slowly grown into a business hub for the Asia-
Pacific region, attracting more than 7,000 multinational corporations, 4,000 of which
have regional functions (Singapore Economic Development Board 2006).
Unlike many of the countries in this region, Singapore did not have natural
resources on which it could rely for revenue. Therefore, the Singaporean government
had to make a concerted effort at growing its economy from scratch, and has done so
with a history of heavy, strategic investments in specific industries in which it felt it
could succeed. Singapore has relied predominantly on tourism and has had to find ways
to attract multinational corporations to its country, which would inevitably have a
positive effect on the surrounding area. This has been done by finding a niche in the
market, identifying a way that Singapore could fill this niche, and then making the
economic conditions as favorable as possible to convince companies to locate there. This
planned approach has worked well for Singapore in the past, a prime example of which
was the influx of petrochemical manufacturing in an area called Jurong Island. As was
related to me in an interview, this island was actually seven separate islands which were
land-filled to create one large island. Petrochemical manufacturing plants were then set
up in this area, attracting many companies and securing a foothold for Singapore in this
industry.
Biocluster Leadership and Planning
It is not surprising, therefore, that a similar planned approach has been used for
the development of the Singapore biocluster. The Singapore Economic Development
Board (SEDB), a branch of the Ministry of Trade and Industry, has a vision for the
Singapore biocluster to become the Biopolis of Asia, an "international biomedical
sciences cluster advancing human health through the pursuit of excellence in research and
development, manufacturing, and healthcare delivery". Within the industry sectors,
namely pharma and biotech, med tech, and healthcare services, Singapore has identified
strategic functional roles along the value chain in which it would like to develop
expertise, and it is making investments accordingly. The direction, vision, and financial
support is provided by the Singaporean Government; this strategy has been termed
"coordinated, long-term, and pro-business" (SEDB 2006). A Biomedical Sciences
International Advisory Council, consisting of top scientists and researchers from around
the world, has been appointed to provide the needed leadership and direction for the
cluster. Three key government agencies are involved in the development of the
biomedical sciences sector, identified as follows:
* Singapore Economic Development Board (SEDB): SEDB is the lead agency
that plans and executes strategies to develop Singapore as a compelling global
hub for business and investment. The Biomedical Sciences Group within
SEDB works closely with A*STAR's Biomedical Research Council, Bio*One
Capital, and other agencies to develop human, intellectual, and industrial
capital in Singapore, in support of the Biomedical Sciences industry (SEDB
2006).
" Agency for Science Technology and Research (A*STAR): A*STAR is
Singapore's lead agency for fostering world-class scientific research and
talent for a vibrant knowledge-based Singapore. It oversees twelve research
institutes and supports research through competitive grants in the wider
scientific community such as public universities and hospitals. The
Biomedical Research Council within A*STAR specifically oversees the life
sciences research institutes, of which there are six (SEDB 2006).
* Bio*One Capital PTE LTD: Bio*One Capital is a leading dedicated
biomedical sciences investment management company in Asia with a
worldwide presence. With funds over 600 million USD, investments are
focused on promising global biomedical companies who are interested in
growth strategies in Asia through their operations in Singapore (SEDB 2006).
These government agencies allow a coordinated effort in providing the direction,
leadership, and funding needed to build the Singapore biocluster.
A*STAR has six institutes in the life sciences sector, each focused on a specific
area of basic research. For example, the Institute of Molecular and Cell Biology was
established in 1987, and with a staff of 450, its research is focused on structural biology,
infectious diseases, and cell cycle control, to name a few areas (SEDB 2006).
Cluster facilities and members
With the aforementioned structure in place for cluster leadership and funding, the
government then decided to build a facility that would allow for the co-location of the
public research institutes and the private companies they were hoping to attract to the
region. After a $500 M investment, the Biopolis was built (see Figure 7). A heptad of
buildings, named Helios, Nanos, Proteos, Genome, Matrix, Centros, and Chromos, are
interlinked by skybridges and provide a campus-like atmosphere, also housing
restaurants, bars, coffee shops, and book stores (Ho 2005).
Figure 7. Map of the Biopolis shows the seven buildings that are already built, as well as those that have
been planned for the next phase of development. Source: Singapore Economic Development Board 2006
The Biopolis was envisioned to be the premier biomedical services R&D Hub in
Asia, providing office and laboratory space to both public and private entities. With
shared facilities that include a wide range of scientific and support services, it provides a
"plug-and-play" model that is attractive to large companies and start-ups alike. The
scientific services include confocal microscopy, DNA sequencing, flow cytometry, and
histology, to name a few. The support services are inclusive of glassware washing,
media preparation and a supply center for Biopolis inhabitants (SEDB 2006). In addition
to the co-location enabled by the newly built Biopolis, Singapore has two "Science
Parks", dedicated to companies in the life sciences industry. The Science Parks are
nearby to the Biopolis, and together these three areas form the majority of what would be
considered the Singapore biocluster.
Before the strategic push into the basic research area of the life sciences began,
Singapore had already been successful in attracting many large pharmaceutical
companies, including Pfizer, Novartis, and GlaxoSmithKline, to their designated
biomedical manufacturing area of Tuas. While technically a part of the Singapore
biocluster, most in the Biopolis and Science Parks do not interact with the manufacturing
companies in Tuas. However, companies that have manufacturing facilities in Tuas are
being invited to join the Biopolis through the establishment of branches of their research
divisions in Singapore.
Aside from government-funded research institutes, which are part of the Ministry
of Trade and Industry, basic research is also pursued at the two large universities in the
area. These universities, namely National University of Singapore and Nanyang
Technological University, are part of the Ministry of Education. Also, on the clinical
side, there are two hospitals, namely National University Hospital and Singapore General
Hospital, which are also part of the cluster.
Government incentives
The last issue that the Singaporean government had to address when planning and
building this man-made biocluster was one of incentives. They had to find ways in which
to attract multinational corporations to the Biopolis and also to build the local workforce
for these corporations through development of human capital within the region.
The terms used to attract multinational corporations are predominantly in the form
of tax incentives or credits. While there are no direct subsidies, there are allowances for
qualified capital expenditures, and tax holidays on qualifying activities. In addition, there
are low tax rates on royalties, as well as a low general corporate tax rate (SEDB 2006).
Human capital development has a two-prong approach. The first is the
recruitment of well-known international talent, those respected in their fields of study, in
order to attract others to follow. This has been quite a successful endeavor, with many
American, European, and Asian scientists heading to the region. The second method by
which human capital has been targeted for development is through the A*STAR
scholarship program. The goal of these scholarships and fellowships is to build a
pipeline of well-trained local scientists, by sponsoring top Singaporean scholars pursuing
degrees in the life sciences through their attendance at foreign, world-renown
universities. These scholars then return to Singapore and join the workforce in
companies or institutes within the cluster for a contractual six years (Yeo 2007). Each
A*STAR scholar is a 10 year, $1 M (Singaporean dollar) investment on behalf of the
government, which includes tuition, living expenses, insurance, stipend and monthly
allowance (SEDB 2006).
Biocluster History Comparison
The San Diego and Singapore bioclusters offer an interesting comparison with
regards to their history of formation and current maturity. San Diego's 40-year biocluster
history includes the founding of major research entities and the nucleation of many start-
ups from the Eli Lilly-acquired Hybritech. Through a semi-planned process, the cluster
has grown to become one of America's biotech hotbeds. Singapore's 40-year
independence has been characterized by government-driven, strategic industry
investments, most recently in the life sciences space. Still in an embryonic state, this
planned cluster has been successful in attracting talent from around the world, both in an
advisory and management capacity.
While differences do exist, it is interesting to note that stakeholders in both the
San Diego and Singapore bioclusters are highly concentrated in specific geographic
areas, suggesting the value of physical proximity in the development of a cluster. For
San Diego, the co-location on the Torrey Pines Mesa and surrounding areas was initiated
via a semi-planned process and further honed by the needs of the cluster members. In
Singapore we see a more literal definition of co-location, with public and private entities
housed in the same campus of the Biopolis, by design.
Another striking similarity can be found in the order of development that has
occurred within these clusters. Whether organically or organized, both areas started by
building pillars in basic research, with four such organizations in San Diego and the
A*STAR institutes in Singapore. The pillars then had spinoffs, either through technology
licensing or startup companies, that slowly started the cluster building process. Next was
the establishment of a key biotech company, with Hybritech in San Diego and many
current attempts at doing the same in Singapore. These key biotech companies had or will
have resulting spinoffs. The introduction of large pharmaceutical firms in each location
logically follows, bringing jobs and perhaps brand recognition to the area. Lastly, the
local collaborations provide the glue to hold the cluster together, as we explored in this
study. This review of historical development of the San Diego and Singapore clusters
therefore suggests a model for building a biocluster.
Methodology
Questionnaire Design
An interview questionnaire was created to understand the various aspects of
collaboration within each respective biocluster. (Please refer to Appendix E to view
Interview Questionnaire in its entirety). It was designed to be thirty minutes in duration
and consisted of a short list of open-ended questions, followed by four key sections:
1) productivity, 2) human capital, 3) infrastructure, and 4) cluster culture. As this was a
fairly qualitative topic, I was interested in ways to objectively compare results across
interviews; I therefore included quantitative measures wherever possible. Typically a
lichert scale (one [low] to seven [high]) or percentages were used to standardize
responses for comparison purposes.
In the development of the questionnaire, sub-goals for each of the sections were
first identified, and questions were then designed to elicit information relevant for these
sub-goals.
Review and Refinement of Questionnaire
Meetings with nine key individuals, many experienced in the questionnaire design
process (please see Appendix B: Questionnaire and Interview Design Guidance), were
helpful in the design and review of the interview questionnaire. Covering a breadth of
backgrounds, from academia to industry to economic policy, their respective feedback
allowed for additional refinement and simplification of the questionnaire for the purposes
of achieving the goals of this project.
Open-ended questions
A short list of high-level, open-ended questions was used to capture the
interviewee's initial perspectives. It was intentionally designed in this manner, so as to
prevent the interviewee from focusing on specific aspects of the collaborative endeavors
in which they were involved, as would occur in subsequent parts of the questionnaire.
The sub-goals for the open-ended questions were as follows:
* Characterize the interviewee's specific role in the biocluster.
* Inform the general thesis question of the key barriers and enablers of
collaboration in their specific biocluster.
* Gain an understanding of the interviewee's perspective of the overall health of the
collaborative environment within their respective biocluster.
* To survey their views on if and/or how the existence of the biocluster has affected
their respective city/country.
Following are the questions that were designed to achieve the aforementioned sub-goals:
1. Referring to the definition of the biocluster, as depicted in Figure 1,
a. How do you participate in the biocluster?
b. Is this the way you would have described it?
2. How would you characterize the collaborative environment within the biocluster?
a. How would you rate the collaborative environment within the biocluster
(on a scale from one [low] to seven [high])?
b. What do you see as the impact the biocluster has had?
3. What are the top three enablers of effective collaboration within the biocluster
community? Why?
4. What are the top three barriers to effective collaboration within the biocluster
community? Why?
Time allotment for the open-ended questions was approximately ten minutes, and
additional clarification questions were included as needed.
Part 1: Productivity
This section was the longest of the questionnaire, as it encompassed many aspects
that are pertinent to the subject at hand. Of specific interest was an understanding of
which were the most common collaborative agreements for the interviewed entities
within each cluster, and how these collaborations were structured. One key piece of
productivity is measurement, therefore it was important to understand if and how the
success of these collaborations was being measured over time. There is also a subjective
component to collaboration, namely preferences for working styles or personality types
that may play into the selection process when determining a collaborator. This also has
an effect on the ultimate end result, and could prove to be a barrier or enabler for
collaboration. Lastly, simple co-location of entities within a geographic biocluster does
not necessarily correlate with collaboration, so it was of interest to survey what
percentage of these individuals were working together as opposed to simply co-existing
within the same geographic space.
The specific sub-goals for this section were as follows:
" Characterize the types of collaborations the interviewee is currently involved in.
* Identify measurement and selection criteria for these collaborations, as well as for
their respective collaborative partners.
* Gain an understanding of whether these are local vs. worldwide collaborations.
The following questions were therefore designed to obtain the information needed to
inform the sub-goals:
1. What types of collaborations are you currently engaged in? (Examples would
include basic research, co-authoring papers, collaborative studies, manufacturing
capabilities, fee-for-service, etc.)
a. Are these bi-lateral vs. multi-lateral (%)?
b. What are the possible outcomes of such collaborations?
2. Academia: Is there a pro-publication bias?
Finance: What trends do you find in life science investments? Do they typically
follow changes in the general economy?
3. Do you have specific goals and performance metrics around each of your
collaborations? If so, what are they?
4. How much of a role does interest in the technology play in your decision of
whether or not to engage in collaboration (%)?
5. What are the criteria used to select a collaborator?
a. What are the criteria used to decide whether to continue working with
them?
b. What are the criteria used to terminate a collaboration?
c. Is this a formal or informal process?
6. Of the collaborations you are currently involved in:
a. What percentage has breakthrough potential in your mind (where
breakthrough is described as novel in field) (%)?
b. What percentage is in the local biocluster (%)?
c. If external to local biocluster, are they in other bioclusters?
7. What is your perception of return on investment (ROI) to your organization on
these collaborations?
8. What percentage of your time is spent working with others in the local biocluster?
Time allotment for this section was approximately ten minutes and questions were
tailored to the interviewee as needed. For example, when meeting with a start-up
company the concept of ROI would not necessarily be applicable, so the words "return"
or "goals" were used as replacement for the term ROI to complete the question.
Part 2: Human Capital
This section was designed to understand the recruitment, training, and retention of
talent within each of the organizations interviewed, and whether the surrounding
biocluster has an influence on any of these aspects. Employee turnover was also an area
of interest, specifically as it relates to whether the turnover was within the local
biocluster. The development of a strong industry-specific talent pool is considered to be
one of the natural byproducts of a cluster, and I therefore wanted to understand how this
played out in each of the respective bioclusters. Did this truly lead to more job
opportunities for these individuals? Did clusters develop around the talent or did they
import the talent from other areas? The specific sub-goals for this section were defined
as follows:
* Identify the incentives used by organizations within the cluster in the
recruitment and retention of talent.
* Survey how many organizations provide training for their employees and
whether this training was somehow encouraged or subsidized by the
government, or another entity.
* Quantify the typical turnover rate for the cluster, as an aggregate of turnover
rates of the individual organizations, and measure whether the turnover
remained within the cluster, moved to other bioclusters, or left for other areas.
* Understand the sources of human capital / talent for the entities within the
biocluster, and whether the local academic institutions were truly feeding this
talent pool.
The questions that were used to obtain this information were as follows:
1. What incentives are provided in the recruitment of talent?
2. What percentage of individuals that you hire is locally educated?
3. What kind of training is provided for the local workforce?
a. What training incentives are provided in the cluster (by government,
industry, associations)?
b. How available are such programs to your employees?
4. What is the turnover rate of your organization?
a. Is the turnover within the cluster or do people leave for other areas?
b. Where do people go when they leave? Is it to an organization that has
a similar area of focus?
5. What incentives are provided to retain talent?
a. Are there policies in place for families and dual careers? Subsidized
housing? Day care?
b. Are there incentives to travel to external conferences/ professional
meetings?
Time allotment for this section was approximately eight minutes.
Part 3: Infrastructure
This section was meant to hone in on the economic and public policies that may
play into the promotion of collaboration within the bioclusters. This was assumed to be a
key role in the Singapore biocluster and therefore was built into the questionnaire so as to
provide a baseline for standardization.
Also, structured opportunities for networking, such as trade associations and
industry interest groups, often provide a forum for the genesis of collaboration. It was of
interest to understand how robust and active these support organizations were in the
respective bioclusters and whether the events and services provided proved to be enablers
for collaboration.
Intellectual property remains the center of the product development game.
Therefore, information regarding patent filing protocols and division of patent royalties
were of interest in case they had any bearing on the way in which individuals chose their
collaborative partners.
The specific sub-goals for this section were as follows:
* Identify the economic and public policies that serve as enablers or barriers to
collaboration within the biocluster.
* Understand the structured opportunities for networking that exist within the
cluster, and the way in which the interviewee participates in these events.
* Obtain information surrounding the intellectual property protocols for the various
entities and the way in which proceeds were divided amongst participants.
The questions designed to achieve these sub-goals were the following:
1. What economic policies (e.g. tax credits, permits, facilities) and other public
policies are in place that are:
a. Enablers for collaboration?
b. Barriers to collaboration?
2. What formal structure(s) does the cluster provide for collaboration (e.g. group
purchasing policies, training, networking, job websites)?
a. How do you participate in and access them?
b. Do you find these valuable?
c. Are there trade associations present and active within the cluster?
3. Are there policies in place that make hospitals accessible for research?
4. Are there protocols in place for patents? Licensing?
a. Can you easily access them? On a scale from one to seven, rate them.
b. How are proceeds from licenses/patents divided amongst participants?
c. Whose name is on the patent?
Time allotment for this section was approximately seven minutes.
Part 4: Cluster Culture
The last portion of the questionnaire was dedicated to gaining an understanding of
the culture within the cluster. For example, was this a risk-averse culture that would shy
away from innovative concepts that were disruptive in nature, or was the cluster
environment conducive to fostering new and fresh ideas? Given that there are many
aspects and subdivisions of the life sciences industry, it is of interest to note whether
specific therapeutic areas or types of research were pursued more than others. Also, as
the interviewees were in a position to speak from an informed perspective, where did
they see the cluster five years from now? In which ways would it develop and how
successful did they feel the cluster would be? While sharing an identity to some degree
when facing the outside world, as members of a specific geographic biocluster, what
were the internal dynamics of the cluster really like? Was there a desire to work with
specific institutions or entities? Lastly I was interested in understanding how competitive
the environment was and whether this impeded on their ability to collaborate with others.
The specific sub-goals identified for this section of the questionnaire were as follows:
* Survey the interviewees for their opinions as to the future growth of the cluster.
* Identify the dominating culture within the cluster.
* Characterize the level of competition within the cluster and how worried
individuals were with regards to disclosure of sensitive information.
* Note the entities that were the most desired collaborative partners.
The questions that were designed to elicit the information needed were:
1. What would you say is the dominating culture in the cluster? (e.g. one of starting
businesses, basic science research, other)
2. How much economic growth (job creation, revenue generated) do you see in the
cluster in the next five years (%)?
3. Who are the most desired collaborative partners within the cluster?
4. How worried are you about disclosing sensitive information to others within the
biocluster (scale of one [low] to seven [high])?
5. Are there knowledge spillovers from these collaborations? If so, what types of
collaborations most often lead to knowledge spillovers?
Time allotment for this section was approximately five minutes.
Mock Interviews
In order to prepare for the interview process, I conducted two formal mock
interviews, each in a timed setting. The first was with an individual who had extensive
business development experience in a large pharmaceutical firm. He was able to ensure
that the questions were self-explanatory and not confusing in nature, specifically given
his experience from a scientific and business perspective. This mock interview candidate
was chosen to verify that the questionnaire would be appropriate for two of the subsets of
individuals I would be meeting with, namely academia and industry. The second mock
interview was with an individual with many years of experience at a large financial firm,
who also happened to be a current degree candidate for graduate work in public policy.
She was able to comment on the applicability of the questions to those in the remaining
two subsets of individuals I would be meeting with, namely government and finance.
It was important to review the introductory presentation as well as the
questionnaire with individuals who had not been involved in the design process as it
provided a level of objectivity needed for further refinement of the interview process.
After each mock interview, a discussion of approximately thirty minutes ensued, which
consisted of reviewing the materials and noting suggestions on how I could further
simplify certain concepts or guide the interviewee to think on the macro-level that would
be needed to complete the questionnaire.
Interviewee Selection
It was crucial to obtain meetings with individuals who would be able to comment
on all four aspects of the questionnaire, namely productivity, human capital,
infrastructure, and cluster culture. This therefore required speaking with those in fairly
senior positions who would be able to provide a broad perspective. The interviewee
selection strategy was to meet with a majority of the active collaborative institutions in
each cluster, while maintaining a breadth across the four key stakeholder groups, namely
academia, industry, government, and finance. Chairmen of active trade associations in
each area were also targeted for interviews. Potential interviewees were contacted via
email and personal introductions. This process resulted in a well-rounded interview set
consisting of eighteen individuals in the San Diego area and sixteen in Singapore, all of
whom were able to provide informed answers to the questionnaire from a variety of
perspectives (for additional details, refer to Appendix C: Interviews Conducted).
Interview Process
A standard format was followed in each of the interviews conducted, as shown in
Figure 8. With a planned duration of one hour in length, a typical interview began with
an introduction to the project using a brief slide deck. The slides provided a macro-level
view of the project goals, a description of the questionnaire I would be going through,
and a list of the types of individuals I was meeting with for this project. Discussions
surrounding my hypotheses were not encouraged as I did not want to influence the
interviewees answers in any way.
Figure 8. Standard interview process consisted of a brief introduction to the project, a discussion of
interviewee background, followed by the four key questionnaire areas (productivity, human capital,
infrastructure, and cluster culture) as depicted above.
The one-hour interview time slot was typically divided as follows:
* Introduction to project, interviewee background, and open-ended question
section of the questionnaire: 25 minutes
* Part 1: Productivity: ten minutes
* Part 2: Human Capital: eight minutes
* Part 3: Infrastructure: seven minutes
* Part 4: Cluster Culture: five minutes
Any remaining time was spent answering questions about the study and further
identifying other individuals within the cluster with whom I could meet.
Data Analysis
After conducting 34 interviews, the data was collected and analyzed in three
distinct ways. First, it was reviewed by biocluster to see if there were clear trends within
the data on this level. Second, while still on a biocluster level, the data was then divided
into the key stakeholder groups, to determine if there were similarities in the perspectives
of individuals from the same group. Third, the stakeholder group analyses were
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combined for an aggregate view, enabling identification of trends amongst these groups,
irrespective of biocluster.
Statistical Testing
To further analyze and denote significant trends within the data, statistical testing
was done. The T-test for equality of means, assuming equal variance, was used, as was
the Z-test, which allows comparison of proportions. Regressions were also run to
identify correlations amongst data variables. Microsoft Excel was used for the statistical
testing, and both Excel and STATA software were used for regression analyses.
Collaboration Scoring Model
In order to test the first hypothesis, the data had to be analyzed in a way that
would determine a Collaboration Score for each of the bioclusters. This allows for an
objective comparison of the relative collaborative environments, and enables an answer
to the first hypothesis to be determined. The first hypothesis stated that Singapore will
prove to be a more collegial and collaborative environment than San Diego, with a higher
percentage of local collaborations. Therefore, I simply collated all of the data that would
be relevant to answer this question and developed the Collaboration Scoring Model seen
in Figure 9. The data from the interviews was reviewed and questions which provided
information that directly related to the collaborative environment within the cluster were
used to inform this model. These questions were divided into three categories, namely
environment for collaboration, local touch points, and human capital. All of the
questions were then directly translated to a scale from one to seven to create an equal
basis for comparison and then added together to arrive at a Collaboration Score. This
was done on a per-interviewee basis, and the interviewee Collaboration Scores were then
aggregated to determine an overall biocluster Collaboration Score.
Collaboration Scoring Model
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Figure 9. The Collaboration Scoring Model consisted of three key categories, which are all crucial to
determining the health of the collaborative environment within the biocluster. The three categories were
environment for collaboration, local touch points, and human capital, and all three were directly informed
by the numerical results of the questionnaire.
Environment for Collaboration
The data points in this category were directly pulled from two of the questions
asked during the interview process, namely:
* How would you rate the collaborative environment within the biocluster (on a
scale from one [low] to seven [high])?
* How worried are you about disclosing sensitive information to others within
the biocluster (on a scale of one [low] to seven [high])?
The first question speaks to the general feeling of openness within the cluster, and how
conducive it is to engaging in collaborative endeavors. A higher score for this question
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was determined to have a positive effect on the overall Collaboration Score. The second
question asks about the competitiveness within the cluster. A lower score, in this case,
would be indicative of a more collegial environment, and therefore the inverse (seven
minus the response given) was added in the determination of the Collaboration Score.
Local Touch Points
This category included three questions from the interviews that directly related to
the local touch points engaged by individuals within the cluster, namely:
* Of the collaborations you are currently involved in, what percentage is in the
local biocluster (%)?
* What percentage of your time is spent working with others in the local biocluster
(%)?
* What formal structure(s) does the cluster provide for collaboration (e.g. group
purchasing policies, training, networking, job websites)? Do you participate in
these?
For each of these questions, I simply took the responses for each biocluster
member and converted them to the scale needed for this model. By looking at the
percentage of local collaborations, the percentage of time spent working with others
locally, and the percent of individuals attending local networking events, I was able to
obtain a fairly accurate reading of the extent to which cluster participants engage in their
immediate biocluster community.
Human Capital
This section was designed to look at the recruitment and retention of human capital
within the biocluster. By focusing solely on data from the following two questions, I was
able to determine the way in which the cluster entities interacted with local talent,
basically an input-output model. The questions used to inform this section were:
* What percentage of individuals that you hire is locally educated?
* Does the turnover from your organization remain within the cluster or do people
leave for other areas?
Again, as the answers were in percentages, I converted them directly to the scale needed
for the purposes of the model.
Calculations for Collaboration Scoring Model
All calculations for the collaboration scoring model were straightforward
conversions from the results obtained via the interview questionnaire. In order to enable
direct comparison of each of the data points of interest, I needed to translate them to a
uniform scale. I chose the scale of one [low] to seven [high] for this purpose, as it was
already being used extensively in the questionnaire. Therefore, to convert from
percentages, I simply assigned 100% the value of 7, such that every 14.29 percentage
points was equivalent to one point on the new scale (100/7 = 14.29). For example, if an
interviewee indicated that 53% of their collaborations were within the local biocluster,
this would contribute 3.7 points (53/14.29) to the Collaboration Scoring Model.
The responses to seven questions were used as inputs to the model, each of which
was converted to a scale of one to seven, resulting in a total possible point value of 49
points. Collaboration Scores were calculated on a per-interviewee basis which, when
aggregated, provided an overall Collaboration Score for the biocluster. Given the
variation in the number of interviewee responses received for these questions, I built
three specific scenarios to be tested, the details of which are as follows:
* Base case: The base case calculated the Collaboration Scores of those individuals
who had responded to all seven of the questions.
* First modification case: This scenario calculated the Collaboration Scores of
those individuals who had responded to five or more of the questions. The scores
were then normalized to account for the number of questions answered by the
interviewee.
* Second modification case: This scenario calculated the Collaboration Scores for
those individuals who had responded to at least one of the seven questions.
Again, the scores were normalized to account for the number of questions
answered.
The reason for the development of the three aforementioned scenarios was that each
subsequent scenario beyond the base case allowed for an increase in sample size via an
expansion of the inclusion criteria. This would provide further confirmation as to the
value of the resulting Collaboration Scores for each of the bioclusters, as well as enable
testing for statistically significant differences between the scores of each cluster.
The Collaboration Scoring Model was also used to analyze collaborative behavior
on a stakeholder level, aggregated across bioclusters. In this case, however, the first
section of the model was not taken into account, as it speaks to the general collaboration
environment within the cluster instead of to the specific role of the interviewee, thereby
making it irrelevant. Responses to five questions were therefore used as an input to this
modified version of the Collaboration Scoring Model, resulting in a total possible point
value of 35 points. Similar to the biocluster Collaboration Score calculations, two
scenarios were tested in this case, as follows:
* Base case: The base case calculated the Collaboration Scores of interviewees that
provided responses to all of the five questions.
* First modification case: This scenario calculated the Collaboration Scores of
interviewees that provided responses to at least three of the five questions. Scores
were then normalized to account for the number of questions answered.
Similar to the biocluster Collaboration Score scenarios, the stakeholder Collaboration
Score scenarios listed above provided a method for confirmation of the resulting scores
through an increase in sample size.
Formality of Approach Scoring Tool
Another tool was developed to review the data as it relates to the second
hypothesis, namely the formality with which each cluster approaches collaborative
endeavors. This tool was called the Formality of Approach Score and included three
specific pieces of data that spoke to the way in which the clusters engaged in
collaborations and their use of productivity metrics to measure performance.
Specifically, the three interview questions used to inform this score were:
* Do you have specific goals around each of your collaborations?
* Do you use performance metrics in each of your collaborations?
* Is the process of selecting a collaborator a formal or informal one?
As all of the data collected in this case was in the form of percentages, a simple average
was used to calculate the final Formality of Approach Score for each cluster. To
maintain consistency with the other relative scoring tool, this score was also translated to
a scale from one to seven. The total possible point value for this tool was therefore 21
points. The Formality of Approach Scoring tool was also used to analyze the data on a
stakeholder level to see if there were significant differences in the behavior and approach
of different stakeholder groups.
Results
For purposes of confidentiality, per the requests of the interviewees, results have been
aggregated and will be reported in two ways: by biocluster and by stakeholder group.
Results will be compared and contrasted in the Discussion section of this thesis.
Questionnaire Results Aggregated by Biocluster
San Diego Interview Results
A total of eighteen interviews were conducted in the San Diego biocluster. The
interviewee responses are aggregated by question for each of the sections of the
questionnaire.
Open-Ended Questions
The top three enablers for collaboration within the San Diego biocluster (note:
more than one answer was allowed) were:
1) Proximity to each other made it easier to network and communicate (44%);
2) Existence of strong research institutions in the area created a hub for
collaborative endeavors (33%);
3) Events held by trade associations such as BIOCOM and CONNECT provided a
forum by which to meet individuals with whom they could collaborate (33%).
There were eighteen respondents to this question. Other responses included: the
desire to work together and promote the cluster helped to enable collaborative
endeavors; there was a need to work together due to increasing specialization of
skill sets; the natural entrepreneurial mentality of many in the cluster promoted
collaborations; and lastly, the weather proved to be an enabling factor for many.
* The top three barriers to collaboration within the San Diego biocluster (note:
more than one answer was allowed) were:
1) Competition or conflicts of interest kept many from working together (50%);
2) Lack of investment capital due to limited venture capital presence prevented
some from collaborating (44%);
3) Issues related to intellectual property and technology transfer proved to be a
barrier to collaboration (33%).
There were eighteen respondents to this question. Some also said that the lack of
available time and resources, given that many entities in the area are start-up
companies, often prevent collaborations from occurring. Others cited the lack of
large company presence as well as the high costs in the area, resulting in less
capital available for other endeavors, as barriers to collaboration.
* When asked to rate the collaborative environment in the San Diego biocluster on
a scale from one [low] to seven [high], the following results were obtained:
Average 4.9
Minimum 1
Maximum 7
Standard Deviation 2.0
N (Number of Respondents) 18
When I divided the interviewees into their respective stakeholder groups and then
viewed the responses regarding the collaborative environment, again on a scale
from one [low] to seven [high] for the San Diego biocluster, I found the
following:
Academia Industry Finance
Average 5.1 4.1 5.6
Minimum 1 1.5 4.5
Maximum 7 6.5 6.5
Standard Deviation 2.5 2.0 0.9
N (Number of Respondents) 5 8 4
Part 1: Productivity
* When asked what percentage of their collaborations were bilateral (indicating two
parties are involved in the collaboration) vs. multilateral (three or more parties),
the aggregate responses were as follows:
Bilateral Multilateral
Average 57% 43%
Minimum 0%
Maximum 100%
Standard Deviation 42%
N (Number of Respondents) 17
Viewing the responses by stakeholder group, I found the following preferences
for type of collaboration agreement:
m Bilateral
m Multilateral
Academia (N=5) Industry (N=8) Finance (N=4)
* Measurements of productivity: 88% of the seventeen respondents indicated they
had goals for their collaborations while 41% had delineated specific performance
metrics for the same. Viewing these responses by stakeholder group, I found the
following:
100 -
90 -
80 -
70 -
60 -
50 -
40
30
20
10 -
0
100 I Goals I 100
Academia (N=5) Industry (N=8) Finance (N=4)
* The role of interest in collaboration: Interest in a technology or idea served as a
decision point of whether to engage in a collaborative endeavor for 58% of the
seven respondents.
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* Choosing a collaborator with whom to work: Seventeen respondents indicated
that the top three qualities they look for in a collaborative partner are as follows:
1) Credibility and strong track record of previous successful collaborations (35%)
2) Strategic fit for the project (35%)
3) Expertise in a specific subject or area (35%)
Other responses included personal integrity, what the partner can offer regarding
complementary strengths, and the desire to work with those who are a good
cultural fit with their organization.
Another related question polled the process by which collaborators are chosen;
50% of the seventeen respondents labeled it as a formal process and the other half
as an informal one. When results were viewed by stakeholder group, this
question showed a marked difference in preferences:
Academia (N=5) Industry (N=8) Finance (N=4)
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* When asked what percentage of the collaborations interviewees are currently
involved with that have breakthrough potential in their mind, responses were:
Average 55%
Minimum 10%
Maximum 100%
Standard Deviation 35%
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N (Number of Respondents) 13
Local Biocluster Collaborations: Of the collaborations they are currently
involved with, interviewees were asked to estimate what percentage were within
the local biocluster, as well as what percentage of their time was spent working
with others in the local biocluster. Responses were as follows:
Collaborations in Time spent working with
local biocluster others in local biocluster
Average 41% 29%
Minimum 0% 0%
Maximum 100% 100%
Standard Deviation 35% 31%
N (Number of Respondents) 17 17
Viewing these responses by stakeholder group revealed the following results:
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Part 2: Human Capital
* Recruitment of talent: When asked what percentage of individuals hired were
locally educated, fifteen respondents indicated this was the case for an average of
33% of their workforce. Viewing the tendency to hire local talent by stakeholder
group revealed the following results:
Academia Industry Finance
Average 23% 22% 61%
N (Number of Respondents) 5 6 4
* Training Opportunities: Of the eight respondents to this question, 50% indicated
they offer training for their employees and only one respondent (13%) indicated
that incentives for this training were provided by the government.
* Retention of talent: Statistics regarding turnover rates for the firms of the
individuals interviewed were as follows:
Average 9%
Minimum 0%
Maximum 30%
Standard Deviation 9%
N (Number of Respondents) 16
Of those that indicated a turnover rate greater than
that the talent remains in the cluster.
0% (N = 11), 55% reported
Part 3: Infrastructure
* When asked to identify economic and public policies that enabled or proved to be
barriers to collaboration, none of the respondents named any.
* Formal structures for collaboration: Trade associations BIOCOM and
CONNECT were highlighted as the two most common forums for networking
within the San Diego biocluster. The following were responses to attendance and
satisfaction rates for these events:
% N (Number of Responses)
Individuals attending association events 81 16
Satisfaction rate: % who find these events valuable 74 13
Participation in networking and other formal cluster events did not vary
substantially amongst stakeholder groups:
Academia Industry Finance
Average 80% 71% 100%
N (Number of Respondents) 5 7 4
Part 4: Cluster Culture
* Dominating culture: Eighteen respondents said the following, when asked what
was the dominating culture in the cluster (note: more than one answer was
allowed):
Entrepreneurial / Start-ups and early stage companies 72
Basic Research 50
Other responses included that the current culture was one of survival, and some
indicated that there was a close-knit environment which felt incestuous at times
given that many in the area are serial entrepreneurs who repeatedly choose to
work together.
* Cluster five-year outlook: Interviewees were asked how much growth they
expected the cluster would have over the next five years. Eighteen respondents
indicated the following:
Positive growth rate is expected
No growth or negative growth rate is expected
Too hard to estimate
% of respondents
67
22
11
Of those that indicated the expectation of a positive growth rate over the next five
years, the minimum estimate was 5% and the maximum was 50%.
* Disclosure of sensitive information: When asked to rate how worried they were
about disclosing sensitive information to others, on a scale from one [low] to
seven [high], responses were as follows:
Average 5.4
Minimum 1.0
Maximum 7.0
Standard Deviation 2.2
N (Number of Respondents) 14
The distribution of responses to this question was as follows:
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Results viewed by stakeholder group, on the same scale, revealed the following:
Academia Industry Finance
Average 4.1 5.7 6.5
N (Number of Respondents) 4 7 3
Knowledge spillovers: 67% of the nine respondents indicated that they have often
seen knowledge spillovers from the collaborations in which they are involved.
Most attributed these to cases in which collaboration between academia and
industry was underway.
The San Diego interview results revealed a culture dominated by entrepreneurial
activities and basic research endeavors, with a well-developed support infrastructure
present. A high degree of risk tolerance along with a fairly competitive atmosphere was
perceived to exist within the cluster. There was a noticeable lack of local venture capital
presence, and the industry stakeholder group had the least involvement in interactions
with biocluster members.
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Singapore Interview Results
A total of sixteen interviews were conducted in the Singapore biocluster. Again, I
aggregated the interviewee responses by question for each of the sections of the
questionnaire.
Open-Ended Questions
The top three enablers for collaboration within the Singapore biocluster, as
indicated by the sixteen respondents (note: more than one answer was allowed)
were:
1) Government support, through a variety of efforts including funding, training
grants, and providing direction and leadership to the cluster has been the
dominant enabling factor (47%).
2) The physical proximity of individuals within the cluster, through the co-
location of public and private firms, in designated areas such as the Biopolis,
promoted collaboration (33%).
3) Three additional enablers were each indicated by 27% of the respondents:
1. The open research culture enables collaborative research endeavors
that would not be possible in many other countries.
2. The general availability of research funding makes it easier to
pursue and further develop early stage ideas.
3. The consortia of A*STAR (Agency for Science, Technology, and
Research), which is part of the Singaporean government, promote
and enable collaborations within the cluster.
Other responses indicated that the pro-Singapore mentality that many share served
as an enabler for collaboration, as was the fact that specific government incentives
exist for collaborative (vs. solo) endeavors.
* The top three barriers to collaboration within the Singapore biocluster, as
indicated by the sixteen respondents (note: more than one answer was allowed)
were:
1) Intellectual property and technology transfer processes were cumbersome, and
contractual agreements difficult, as they are time-consuming and have restrictive
deal terms, preventing many from collaborating (53%).
2) Lack of access to risk capital was an issue for many and was cited as a barrier
to commercialization of products in the cluster. Specifically, limited access to
mid-stage capital was highlighted (27%).
3) 20% of respondents indicated a barrier to collaboration was the lack of
networking events and forums for communication on multiple fronts, namely:
1. Between government research institutes and Singaporean universities
2. Between the clinicians/practitioners at local hospitals and those in the
basic research community
Other barriers identified by respondents were that the risk-averse culture
prevented collaboration, as did the limited experience of those within the cluster.
* When asked to rate the collaborative environment in the Singapore biocluster on a
scale from one [low] to seven [high], the results were as follows:
Viewing these responses by stakeholder group (limited to academia and industry,
as they provided twelve of the sixteen total responses):
Academia Industry
Average 4.7 4.6
Minimum 4.0 3.0
Maximum 5.5 6.0
Standard Deviation 0.6 1.3
N (Number of Respondents) 5 7
Part 1: Productivity
* When asked what percent of their collaborations were bilateral (two parties) vs.
multilateral (three or more parties), the aggregate responses were as follows:
Bilateral Multilateral
Average 86% 14%
Minimum 50% 0%
Maximum 100% 50%
Standard Deviation 20%
N (Number of Respondents) 12
Maximum 6.5
Standard Deviation 1.1
N (Number of Respondents) 16
When viewed by stakeholder group, both academia and industry (total N= 10)
showed a preference of 89% for bilateral agreements.
* Measurements of productivity: 92% of the twelve respondents indicated they
outlined goals for their collaborations while 42% had delineated specific
performance metrics for the same. Results viewed by stakeholder group are as
follows:
Academia Industry Finance
Goals 100% 86% 100%
Performance Metrics 33% 43% 50%
N (Number of Respondents) 3 7 2
* The role of interest in collaboration: The nine respondents to this question
indicated that the weight given to pure interest as a decision point of whether to
engage in a collaborative endeavor is 54%.
* Choosing a collaborator to work with: Of the fifteen respondents, 53% indicated
that the most important trait they look for is expertise in a specific area.
Other responses included the time and availability of the individual or company,
how cost effective the collaboration would be for the deciding party, and the
amount of experience the individual had.
Another related question asked the process by which collaborators are chosen;
62% of the twelve respondents reported an informal process and the remaining
38% reported a formal one. When viewed by stakeholder group, the following
preferences emerged:
Mademia (N3)
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* When asked what percentage of the collaborations interviewees are currently
involved with that have breakthrough potential in their mind, responses were:
* Local Biocluster Collaborations: Of the collaborations they are currently
involved with, interviewees were asked to estimate what percentage were within
the local biocluster, as well as what percentage of their time was spent working
with others in the local biocluster. Responses were as follows:
Collaborations in Time spent working with
local biocluster others in local biocluster
Average 49% 19%
Minimum 0% 0%
Maximum 100% 50%
Standard Deviation 38% 15%
Average 50%
Minimum 20%
Maximum 100%
Standard Deviation 32%
N (Number of Respondents) 12
Academia (N=3) Finance (N=2)
2
Tel
N (Number of Respondents) 12 12
Responses viewed by stakeholder group revealed the following:
Part 2: Human Capital
* Recruitment of talent: When asked what percent of individuals they hire were
locally educated, nine respondents indicated this was the case for 72% of their
employees. This number is an aggregate for hiring in all positions (junior level
and management). However, a majority of respondents that management level
positions are often recruited from abroad and that local hiring was mostly done
for junior level positions.
* Training Opportunities: Of the seven respondents to this question, 100%
indicated they offer training for their employees and 71% of these respondents
indicated they were given incentives for this training by the government.
* Retention of talent: Statistics regarding turnover rates for the firms of the
individuals interviewed were as follows:
Of those that reported a turnover rate greater than 0% (N=8), 75% indicated that
the talent remains in the cluster. Also it should be noted that of the eight
respondents, seven were from the industry stakeholder group.
Part 3: Infrastructure
* When asked to identify economic and public policies that enabled or proved to be
barriers to collaboration, a majority of respondents indicated that specific policies
which enabled collaboration did not come to mind, but rather that the leadership,
direction, and support of the government and economic development board set up
favorable environmental conditions in this regard. No specific policy barriers to
collaboration were highlighted, most indicating that they didn't believe any such
barriers existed.
* Formal structures for collaboration: Trade association BIO-Singapore was cited
as the most common forum for networking within the Singapore biocluster.
Many also indicated that A*STAR holds meetings and education events which
also serve the purpose of networking. The following were responses to
attendance and satisfaction rates for these events:
Average 8%
Minimum 3%
Maximum 15%
Standard Deviation 5%
N (Number of Respondents) 8
* Intellectual property protocols: When asked about the way in which patents and
licenses were handled in their respective firms, respondents indicated they
typically file their intellectual property in at least two of the following three
countries: US, UK, and Singapore. Respondents were asked whether there were
formal protocols for patents and licensing, and 100% of the eight respondents
indicated the affirmative. Asked to rate the accessibility of these protocols, on a
scale of one [low] to seven [high], the results were as follows:
Average 6.8
Minimum 6.0
Maximum 7.0
Standard Deviation 0.5
N (Number of Respondents) 8
Part 4: Cluster Culture
* Dominating culture: Sixteen respondents said the following, when asked what the
dominating culture in the cluster was (note: more than one answer was allowed):
Basic Research 75
Manufacturing 18.7
Pursuit of anything that will bring in revenue 18.7
It should be noted that most respondents indicated that there were two very
distinct cultural aspects to the biocluster in Singapore, which never really overlap:
the first being manufacturing, located approximately 30 minutes away from the
main town, and the second being the basic research environment.
* Cluster five-year outlook: Interviewees were asked how much growth they
expected the cluster would have over the next five years. 100% of the twelve
respondents indicated that they expected to see a positive growth rate for the
cluster, with a minimum value assigned being 10% and a maximum at 70%. The
overwhelming majority, however, indicated that growth would mostly come from
manufacturing as basic research would not be far enough along to have revenue-
generating products on the market within a five-year timeframe.
* Disclosure of sensitive information: When asked to rate how worried they were
about disclosing sensitive information to others, on a scale from one [low] to
seven [high], responses were as follows:
Average 3.5
Minimum 1.5
Maximum 6.5
Standard Deviation 1.9
N (Number of Respondents) 11
* Knowledge Spillovers: Of the eight respondents to this question, 63% said they
observed knowledge spillovers from their collaborations. Six of these
respondents were from the industry stakeholder group.
The Singapore interview results revealed an organized approach towards the development
of a biocluster, led and directed by the Singaporean government. The fairly collegial
culture was dominated by basic research endeavors and a high percentage of bi-lateral
collaborations within the cluster. Subject matter expertise was the primary factor when
choosing a collaborative partner. The industry stakeholders were heavily reliant upon the
region for human capital and a high percentage of turnover remained in the area.
Questionnaire Results Aggregated by Stakeholder Group
The data was also aggregated by stakeholder group, to assess whether there were
trends in the way in which stakeholders approached collaborative endeavors, irrespective
of their selected biocluster. Data for three stakeholder groups, namely academia,
industry, and finance, are reported as these groups had the largest participation in the
study, providing 31 of the 34 total interviews conducted for this project. The three
remaining interviews were with government and trade associations. Results are again
shown as they relate to the sections of the interview questionnaire.
Note that open-ended questions were not parsed in this manner, as the responses
would be duplicative of those reported in the prior results section. Also, only questions
for which the responses of key stakeholder groups differed by a noticeable amount are
reported below. It should be assumed that the results of questions for which data is not
discussed in this section were in line with those already presented.
Part 1: Productivity
* Type of collaboration: In looking at types of collaborations that key stakeholders
pursue, namely bilateral vs. multilateral, the following results across the two
bioclusters were obtained:
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* Measurements of productivity: In surveying the way in which key stakeholder
groups structure their collaboration agreements, the following results for
delineation of goals and performance metrics were observed. Note that there
were 29 responses amongst these three stakeholder groups for this question.
* Role of interest in a collaboration: The weight (as a percentage) assigned to the
role that interest plays in the decision of whether to engage in a collaboration was
as follows:
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Academia Industry Finance
Interest in technology or idea 60% 61% 30%
N (Number of Respondents) 5 8 3
* Choosing a collaborator: When asked the process by which collaborators are
chosen, the stakeholder groups indicated the following process behaviors:
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* When asked what percentage of the current collaborations have breakthrough
potential in their mind, responses were:
Academia Industry Finance
Collaborations with 51% 47% 68%
Breakthrough Potential
N (Number of Respondents) 6 13 6
* Local Biocluster Collaborations: Of the collaborations they are currently
involved with, key stakeholder groups indicated the following for the percentage
of collaborations within the local biocluster and the percentage of their time spent
working with others in the local biocluster:
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Part 2: Human Capital
* Recruitment of talent: When asked what percentage of individuals hired were
locally educated, the following results were obtained:
Academia Industry Finance
Percent local hires 36% 46% 64%
Minimum 0% 0% 0%
Maximum 100% 95% 100%
Standard Deviation 50% 31% 41%
N (Number of Respondents) 6 13 5
* Retention of talent: Statistics regarding turnover rates for the firms of the
individuals interviewed were as follows:
Academia Industry Finance
Turnover Rate 11% 8% 8%
Minimum 0% 0% 0%
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Maximum 30% 15% 20%
Standard Deviation 12% 5% 10%
N (Number of Respondents) 6 14 4
For those institutions that experienced turnover greater than 0% (N= 19), the
percentage of turnover that remained in the cluster was as follows:
Academia Industry Finance
Turnover that stays in cluster 38% 65% 100%
N (Number of Respondents) 4 13 2
Part 3: Infrastructure
Formal structures for collaboration: Stakeholder groups did not differ
substantially with regard to participation in cluster networking or educational
events, or with regard to their satisfaction with the same.
Academia Industry Finance
Participation in events 86% 75% 100%
N (Number of Respondents) 7 12 5
Of those that did participate (N=20), the following were the results regarding
relative satisfaction with these events, as they pertain to enabling collaboration:
Academia Industry Finance
Value found in event attendance 75% 73% 90%
N (Number of Respondents) 6 9 5
Part 4: Cluster Culture
Disclosure of sensitive information: When asked to rate how worried they were
about disclosing sensitive information to others, on a scale from one [low] to
seven [high], responses of key stakeholders, regardless of biocluster, were as
indicated below (total N=24).
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* Knowledge Spillovers: Seventeen respondents to this question were from the
three stakeholder groups of academia, industry, and finance. The following
percentages of each group indicated that they observe knowledge spillovers from
collaborations in which they engage:
Academia Industry Finance
Knowledge spillovers observed 100% 56% 50%
N (Number of Respondents) 4 9 4
The interview results, when viewed by stakeholder group, show a clear distinction in the
preferences regarding approach to and engagement of collaborative endeavors for the
finance entities, when compared to academia and industry. This notion will be further
tested via the relative scoring tools.
Collaboration Scoring Model Results
As described in the Methodology section, this relative scoring tool enabled an
objective comparison of the overall environment for collaboration in each of the
bioclusters of interest. Stakeholder Collaboration Scores were also calculated to assess
the relative collaborative behavior of the stakeholder groups.
Biocluster Collaboration Scores
The resulting Collaboration Scores for the San Diego and Singapore bioclusters
are shown in the scorecard below (Figure 10). Singapore rated as the more collaborative
of the two clusters, with 29.3 of 49 total possible points. San Diego received a score of
22.0 points. The difference between Collaboration Scores was statistically significant
(p=0.0421). This model calculated an individual Collaboration Score for each of the
interviewees in the two bioclusters, and then aggregated the responses to enable a view of
the overall collaborative environment. Each data point was pulled directly from the
questionnaire results highlighted earlier, and was transposed into a score from 1 to 7 for
the purposes of comparison. Note that the limitation of this model is that it was only
informed by the questionnaire responses of the interviewees who provided answers to all
of the questions asked, so as to not bias the results. Therefore, the sample size used to
arrive at these scores was limited to nine individuals for San Diego and six individuals
for Singapore.
Collaboration Scorecard for Bioclusters
Environment for
Collaborations
Local Touch Points
Human Capital
San Diego Singapore
Collaborative rating 4.9 4.7
Competitiveness score 1.7 4.3
Local collaborations 2.3 3.0
Time spent working with others locally 1.1 0.7
Participation in networking events 6.2 5.8
Local hires 1.9 5.5
Turnover that remains within cluster 3.9 5.3
Collaboration Score 22.0 29.3
Figure 10. Scorecard with resulting Collaboration Scores for the bioclusters is shown above. The model
was informed via data from interview questionnaire and converted to a uniform scale of one [low] to seven
[high] for comparison purposes.
Modifications to this model were also developed, to explore how the inclusion of
additional interviewee responses would change the resulting Collaboration Scores for the
two bioclusters. The first modification included interviewees who responded to five or
more of the seven questions asked. This corresponded to a sample size of sixteen in San
Diego and ten in Singapore. Each interviewee's collaboration score was then normalized
to account for the number of questions they answered. In doing this analysis, I obtained
the following results:
San Diego Singapore
Average Collaboration Score 23.0 29.0
Standard Deviation 9.1 6.4
With a Collaboration Score of 29.0 of a possible 49 points, Singapore reports a similar
score to that seen in the previous analysis. In this case, I found that the difference
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between the Collaboration Scores of San Diego and Singapore was trending toward
significance.*
A second modification, which further widened the sample size of individuals who
could be included in this analysis, calculated the Collaboration Scores for those
interviewees who had answered at least one of the questions in the scorecard. This now
increased the sample size to eighteen for San Diego and fifteen for Singapore. Again,
scores were normalized to account for the number of questions the individual answered.
This analysis provided the following results:
San Diego Singapore
Average Collaboration Score 24.6 31.2
Standard Deviation 10.5 7.4
The Collaboration Scores seen here are similar to those found in the original and first
modification cases. The difference in scores between San Diego, with 24.6 points, and
Singapore, with 31.2 points, was found to be statistically significant in this case (p-
value=0.03).
Stakeholder Collaboration Scores
A similar analysis using the Collaboration Scoring Tool was done on the
stakeholder level, with a slight modification. I removed the category of environment for
collaborations, as the responses to these questions do not speak to the individual
interviewee behavior, but rather to his/her view of the surrounding biocluster
environment. Therefore, this category includes exogenous factors, thereby creating bias
T-test for equality of means, p-value=0.0812
in the results. The total point value attainable for the stakeholder version of the
Collaboration Scoring Tool would therefore be 35 points.
The base case used in this analysis was inclusive of those participants, across
bioclusters, who answered all of the questions required as inputs for the Collaboration
Score. This translated into a sample size of four individuals from academia, ten from
industry, and two from finance. The resulting scorecard is seen in Figure 11.
Collaboration Scorecard for Stakeholders
Academia Industry Finance
Local collaborations 5.7 1.5 3.0
Local Touch Points Time spent working with others locally 1.9 0.5 3.4
Participation in networking events 7.0 5.6 7.0
Local hires 2.0 3.5 6.8Human Capital
Turnover that remains within cluster 2.6 4.9 7.0
Collaboration Score 19.2 16.0 27.2
Figure 11. Scorecard with resulting Collaboration Scores for the various stakeholder groups is shown
above. Note that only the categories of local touch points and human capital are included in this analysis.
The model was informed via interview data and converted to a uniform scale of one [low] to seven [high]
for comparison purposes.
With a score of 27.2 out of 35 possible points, the finance stakeholder group is clearly
more collaborative than both industry and academia, by this measure. The difference in
scores between finance and industry is statistically significant (p=0.0189). The score
differences between finance and academia, as well as academia and industry, were not
found to be statistically significant.t
A modification to the base case, similar to the analysis done for the biocluster
Collaboration Scores, was conducted here as well. The modification included
t T-test for equality of means, Finance vs. Academia, p-value=0.1066
T-test for equality of means, Academia vs. Industry, p-value=0.2816
interviewees who had answered at least three of the five questions needed to inform the
model. This increased the sample size for each stakeholder group to seven for academia,
fifteen for industry, and five for finance. Again, the scores were normalized to account
for the number of questions the individual answered. The results from the modified
scenario are as follows:
Academia Industry Finance
Average Collaboration Score 20.8 14.3 22.4
Standard Deviation 4.9 6.1 5.4
Finance again had the highest Collaboration Score with 22.4 out of a possible 35 points.
Most notable, however, is the low Collaboration Score of the industry stakeholder group.
A statistically significant difference occurs between the scores of industry and finance
(p=0.0172) as well as between the scores of industry and academia (0.0228). The
difference in scores between academia and finance were not statistically significant.'
Formality of Approach Scores
In a similar manner, the Formality of Approach Score was calculated in order to
address the second hypothesis, and to implement a relative comparison between the two
bioclusters as well as between the key stakeholder groups
Biocluster Formality of Approach Scores
The resulting scores for the San Diego and Singapore bioclusters are shown in Figure 12.
The information used to populate this scorecard was again pulled directly from the
interview results, and was converted to a scale of one to seven. Of 21 possible points,
T-test for equality of means, p-value=0.6156
Biocluster Scorecard
San Diego Singapore
Formality of collaborator selection process 3.5 2.7
Outlined goals for collaborative endeavors 6.2 6.4
Delineation of performance metrics 2.9 2.9
Formality of Approach Score 12.6 12.0
Figure 12. The Formality of Approach Scores shown above indicate that the members
of the San Diego biocluster are slightly more formal in the way in which they approach
collaborative endeavors.
San Diego scored 12.6 points, but Singapore was very close behind at 12.0 points, a
difference that was not statistically significantO. A perfect score of 21 points would
indicate that all of the interviewees within the cluster used a formal selection process
when choosing a collaborator, outlined goals for all of their collaborations, and delineated
specific performance metrics for each of the same.
Stakeholder Formality ofApproach Scores
The Formality of Approach scoring tool was also used to analyze the data for
stakeholder groups, first in aggregate and next on a biocluster level. The aggregate
scores for the stakeholder groups, across both bioclusters, are shown in Figure 13. Here I
find that the finance stakeholder group appears to prefer measurement of their
collaborative endeavors, with high utilization of goals and performance metrics. Also,
the process by which collaborators are selected is conducted in a formal manner, resulting
in a higher Formality of Approach score for this group. I observe a statistically
significant difference in scores between the finance and academia stakeholder groups (p-
4 T-test for equality of means; p-value=0.7629
value=0.0479), and a trend towards significance when comparing the scores of the
finance and industry stakeholder groups (p-value=0.0812).
Aggregate Stakeholder Scorecard
Academia Industry Finance
Formality of collaborator selection process 1.8 2.8 5.8
Outlined goals for collaborative endeavors 7.0 5.6 7.0
Delineation of performance metrics 2.7 2.8 3.5
Formality of Approach Score 11.5 11.2 16.3
Figure 13. The Formality of Approach Scores are shown for each of the stakeholder groups,
aggregated across San Diego and Singapore bioclusters. Financial entities had the highest score,
indicating tendency to engage in a formal collaborator selection process and use of goals and
performance metrics surrounding their collaborative endeavors.
In viewing this information on a biocluster stakeholder level, relatively little variation is
observed in the data, as compared to the aggregate stakeholder Formality of Approach
Scores. The San Diego stakeholder scorecard is shown in Figure 14, and the Singapore
stakeholder scorecard in Figure 15. In San Diego, I do not observe a significant
difference between the finance and academia stakeholder scores , nor between the
finance and industry stakeholder scorestt
** T-test for equality of means p-value=0.1649
" T-test for equality of means, p-value=0. 1619
San Diego Stakeholder Scorecard
Academia Industry Finance
Formality of collaborator selection process 1.4 3.5 6.2
Outlined goals for collaborative endeavors 7.0 5.3 7.0
Delineation of performance metrics 2.8 2.7 3.5
Formality of Approach Score 11.2 11.5 16.7
Figure 14. The Formality of Approach Scores are shown for the San Diego stakeholder groups.
Finance again has the highest score, while academia and industry both show a more informal
approach to collaborations with scores of 11.2 and 11.5, respectively, of a possible 21.0 points.
In Singapore, I also do not observe a significant difference between finance and academia
stakeholder groups. +
Singapore Stakeholder Scorecard
Academia Industry Finance
Formality of collaborator selection process 2.3 2.0 5.3
Outlined goals for collaborative endeavors 7.0 6.0 7.0
Delineation of performance metrics 2.3 3.0 3.5
Formality of Approach Score 11.6 11.0 15.8
Figure 15. The Formality of Approach Scores are shown for the Singapore stakeholder groups.
Here we see a similar trend to the aggregate stakeholder scorecard, with finance scoring the
highest, followed next by academia, while industry has the lowest score of the three, at 11.0.
The Formality of Approach scores provide the ability to distinguish the stakeholders by
their preferences when engaging in collaborative endeavors. Across both bioclusters,
finance shows a consistent preference for increased structure in this regard.
* T-test for equality of means, p-value=0.1328
Discussion
Thus far the interview questionnaire data has been objectively reported and the
historical backgrounds of the two bioclusters of interest have been described. The
additional data that was obtained through the interview process and site visits was of an
observational nature, and therefore this data, as it related to specific points of interest,
will now be mentioned in this section of the paper.
Similar in format to the results section, I will walk through the parts of the
questionnaire, this time comparing and contrasting the data presented by biocluster and
key stakeholder group. Open-ended questions will be discussed at the end of this section
as they, by design, provide a summarized view of the goal of the paper.
Interpretation of Questionnaire Results
Part 1: Productivity
* Types of collaborations: There was a strong trend in Singapore towards bilateral
collaboration agreements, with 86% of individuals (N=12) involved in such
agreements at the time of interview. I observe a marked difference when
compared to San Diego, where only 57% of the respondents (N=17) were
engaged in the same. This difference was highly statistically significant, with a p-
value of 0.0295. Trends were also seen when viewing preferences for key
stakeholder groups in each region. In the aggregated analysis across both
bioclusters, academia and industry had a preference for bilateral collaboration
agreements while finance preferred multilateral agreements. The difference
between the finance and industry stakeholder groups was statistically significant
(p-value of 0.0483), while the relationship between responses for the finance and
academia stakeholder groups was trending toward significance. §§
The strong preference of both academia and industry for bilateral
agreements in the Singapore biocluster speaks to the basic research culture that by
far dominates the area (as cited by 75% of interviewees). The bilateral agreements
could also be the result of the way in which funding grants are given in Singapore,
as many require collaboration with at least one other party in order to receive
funding.
Measurements of Productivity: Responses for delineation of goals and
performance metrics surrounding their collaborations for interviewees in San
Diego and Singapore are shown by the following side-by-side comparison:
San Diego Singapore
Goals 88% 92%
Performance Metrics 41% 42%
N (Number of Respondents) 17 12
These responses did not show a statistically significant difference, indicating that
a similarity in frequency of use of goals and performance metrics exists between
the two bioclusters. However, in both cases, I observed a clear trend amongst the
behavior of key stakeholder groups, again reflected in the aggregate view,
combining data from both clusters. Finance had a higher percentage of
collaborations for which performance metrics were agreed upon (50%, N=6),
when compared to academia (38%, N=8) and industry (40%, N=15). While not
• T-test for equality of means, p-value=0.0933
statistically significant, it does suggest that perhaps a difference in preferences
might exist amongst these groups. Another trend seen on the stakeholder group
level, although not statistically significant, was that industry was less likely to
outline goals for its collaborations (80%, N=15), when compared to finance
(100%, N=6) and academia (100%, N=8).
When one considers the interests of each of the stakeholder groups, this
makes sense. Financial firms are most worried about minimizing downside risk,
and therefore are more apt to use measures by which to ensure productivity of a
collaborative endeavor. Therefore, through the example of the finance
stakeholder group, we begin to see the effect of risk tolerance on the level of
formality used when engaging in collaboration.
* Role of interest in collaboration: While San Diego and Singapore showed similar
averages for the role that interest plays in the decision process of whether to
engage in a collaboration (58%, N=7 and 54%, N=9, respectively), the
stakeholder analysis revealed an interesting trend. Finance was less likely to use
interest as a decision point (30%, N=3), as compared to academia (60%, N=5) and
industry (61%, N=8). These results, although not statistically significant ", do
again imply that a difference in behavior exists amongst the finance stakeholder
group, and a similar view is often shared between academia and industry.
* Choosing a collaborator to work with: It was interesting to note that the key trait
those in Singapore were looking for in a collaborative partner was expertise, with
53% of individuals (N=15) indicating as such. This perhaps explains the recent
Finance vs. Academia, t-test for equality of means, p-value=0.3343
Finance vs. Industry, t-test for equality of means, p-value=0.3674
efforts of the Singaporean government to recruit specialists from around the world
to join its biocluster, as there is a definite need for expertise in certain fields.
In San Diego, a strong track record, strategic fit, and subject matter
expertise all received 35% response. This potentially points to the entrepreneurial
nature which is central to the San Diego biocluster, and the respect given to the
tendency of individuals there to build a track record of previous startup successes
and failures. Anecdotally, and through networking with individuals while
visiting, I found this was definitely the case, as it was common to come into
contact with many serial entrepreneurs.
Another related question spoke to the way in which collaborators were
chosen, and whether this was a formal or informal process. San Diego had 50%
respond that it was a formal process (N=17) while Singapore showed 38%
reporting the same (N=12). This difference was not statistically significantttt
The stakeholder group analysis showed a trend in the preferences of various
groups, both when viewed in aggregate, irrespective of biocluster, as well as on
the stakeholder level within each biocluster. The aggregate responses showed a
difference that was trending toward significance (p-value=0.084) between the
preference of academia to engage in informal collaborations (75%, N=10) and
that of finance, with a preference for formal collaborations (83%, N=6).
Intuitively, when I take this information and combine it with the earlier
noted trend, of the higher use of performance metrics in the finance stakeholder
group, I believe it makes sense. A formal selection process indicates a behavior
pattern that is risk averse, and performance metrics in a collaborative endeavor
Z-test for proportions, p-value=0.795
often serve the same purpose. One can see a general trend by looking at the
following data side-by-side:
Academia Industry Finance
Formal Selection Process 25% 40% 83%
Use of Performance Metrics 38% 40% 50%
N (Number of Respondents) 8 15 6
I observe that the use of performance metrics increases alongside use of a formal
selection process. This point will be further explored via the Formality of
Approach scoring tool later in this section.
Breakthrough potential: When asked what percentage of their collaborations had
breakthrough potential in their mind, San Diego interviewees indicated 55%
(N=13) and Singapore interviewees reported 50% (N=12). Again, very similar
responses were observed in the aggregate, but when viewed on the stakeholder
group level, I begin to see some differences. Combining data from both
bioclusters, I find that those in finance believe that 68% (N=6) of their
collaborations have breakthrough potential, as compared to 51% (N=6) for
academia and 47% (N= 13) for industry.
This information, in addition to previous comments on the differences in
behavior of financial firms as compared to other stakeholders, reveals a trend of
interest. Through higher use of performance metrics, a more formal process of
collaborator selection, and an extremely high participation in cluster networking
events, it may be that the finance firms have figured out the strategy to capitalize
upon the co-location of entities within the biocluster...a notion potentially
reflected in the high percentage of collaborations with breakthrough potential in
which they are involved.
Local biocluster collaborations: Both San Diego and Singapore indicated a
similar average percentage for local collaborations, with San Diego at 41%
(N=1 7) and Singapore reporting a slightly higher value of 49% (N=12). When I
further divide these collaborations into their respective stakeholder groups, while
remaining at the biocluster level, I begin to observe some differentiation.
Academia in both cases has a much higher percentage of local collaborations,
when compared to industry and finance. Side-by-side summary statistics are as
follows:
As noted in prior section, interview responses for San Diego for this question for
academia, industry, and finance were N=5, N=8, and N=4, respectively. For
Singapore, academia, industry, and finance responses totaled N=3, N=7, and N=2,
respectively.
In San Diego, the difference between the percentage of local
collaborations for industry as compared to finance was trending towards statistical
significance (p-value=0.0785), while the difference between academia and
industry was very significant (p-value=0.0085). The difference between
academia and finance was not statistically significant. *tt In Singapore, a
comparison of the responses between academia and industry also showed
statistical significance (p-value=0.0051), as did the difference in responses of
academia and finance (p-value=0.0031). In this case, finance did not differ
significantly in response as compared to the industry stakeholder group. §m§
When viewed in aggregate, across bioclusters, the stakeholder groups
again showed statistically significant trends in collaboration behavior. The
percentage of local collaborations pursued by academia as compared to industry
was highly significant (p-value=0.0002), as was the difference observed between
academia and finance (p-value=0.0135). The local collaborations pursued by
finance and industry did not differ significantly in aggregate.
Also observed were the differences in behavior between bioclusters, on
the stakeholder level. Academia reported the highest percentage of local
collaborations in both areas, and industry indicated the lowest. None of the
differences between stakeholder groups on the biocluster level were statistically
significant.tttt However, of note was the particularly low percentage of local
. T-test for equality of means, p-value=0.3863
" T-test for equality of means, p-value=0. 1225
T-test for equality of means, p-value=0. 1225
. T-test for equality of means; Singapore Academia vs. San Diego Academia, p-value=0. 1478
T-test for equality of means; Singapore Industry vs. San Diego Industry, p-value=0.3902
T-test for equality of means; Singapore Finance vs. San Diego Finance, p-value=0.5342
collaborations pursued by industry in the San Diego area. This most likely speaks
to the small company environment that is common in this region, but does bring
into question the reason industry firms decide to locate here. Referring back to
the factors that often attract firms to an area, I had cited natural resources as one
factor and the ability to achieve synergies as another. In the case of industry in
San Diego, I do not see either factor holding true, as the industry stakeholder
group has the lowest percentage of local collaborations, spends the least amount
of time working with others in the local area, and has the lowest local hiring
percentage of the three stakeholder groups interviewed. Perhaps the question now
becomes, is the increasing presence of industry in San Diego becoming a barrier
to collaboration?
* The last data query in the productivity section of the questionnaire is an estimate
of the time spent working with others in their respective bioclusters. It was
interesting to note that San Diego interviewees reported 29%, N=17, and
Singapore reported 19%, N=12. When combined with the data from the previous
question, in which Singapore had a higher percentage of local collaborations
(49%, N=12) than San Diego (41%, N=17), the results appear counterintuitive, as
one would expect that the amount of time one spends working with others in the
local biocluster would be positively related to the percent of local collaborations
one is involved in.
A closer look at this data reveals that such a relationship does in fact exist
for San Diego. For example, I observe a statistically significant positive
correlation between the time spent working with others in the local San Diego
biocluster and the percentage of local collaborations one is engaged in (p-
value=0.005, correlation coefficient=0.644). Also, on a sub-analysis in which the
San Diego biocluster was further separated into stakeholder groups, I observe a
statistically significant positive correlation in the industry group between the two
same variables (p-value=0.023, correlation coefficient =0.779).
In the same way, many such correlations can be made, relating the
variables presented thus far. For example, another test I ran was to compare the
percentage of local collaborations one engages in and their respective rating of the
collaborative environment within the cluster (on a scale from one to seven). The
results for the stakeholder groups in the San Diego biocluster were not statistically
significant. # Another example is the potential relationship between the role of
interest as a decision point and the percentage of collaborations that have
breakthrough potential. Again, run for the San Diego biocluster, this relationship
was not statistically significant. §§'
Part 2: Human Capital
* Recruitment of Talent: When comparing the responses to this question, it was
quite clear that Singapore, with 72% local hires, was more reliant upon the local
biocluster for human capital than was San Diego, with 33%. The difference in
results was statistically significant (p-value=0.011).
* Regressions for percentage of local collaborations vs. rating of collaborative environment were not
significant for any of the stakeholder groups in San Diego:
Academia, p-value=0.519, correlation coefficient=0.388
Finance, p-value=0.944, correlation coefficient=0.056
Industry, p-value=0.417, correlation coefficient=0.335
" Regression using aggregated responses in San Diego biocluster, for the relationship between interest as
a decision point and breakthrough potential of current collaborations: p-value=0.336, correlation
coefticient=0.480
When looking at local hiring rates by stakeholder group, aggregated across
bioclusters, I also observe differences in practice, although they are not
statistically significant given the small sample sizes interviewed. For example, in
academia I find a 36% rate of local hires (N=6), industry reports 46% (N=13), and
finance indicates 64% (N=5). One possible explanation for the high rate of local
hiring in finance is that the firms might be looking for individuals who know the
cluster well, so as to enable networking which is a significant asset in these firms.
This is supported by the fact that finance interviewees spent an average of 40% of
their time working with others locally, indicating that local networking must be an
important factor.
Another interesting test I ran was to compare the local hiring percentages
of stakeholder groups between bioclusters. This analysis revealed a statistically
significant difference in the local hiring rates of industry in San Diego as
compared to Singapore (p-value=0.0029), with industry in San Diego only hiring
22% of their workforce locally, while industry in Singapore hires 67% locally.
In Singapore, with 72% of the employees hired having been educated
locally, and only two large universities, the city/state might be poised for a
downturn in these numbers in the future, as supply will undoubtedly dwindle.
However, anecdotally while interviewing those in the Singapore biocluster, it was
repeated over and over again that there is a definite lack of PhD level talent in the
area and this is becoming a major problem. Even looking beyond the country to
the region surrounding Singapore, it is difficult to find the PhDs and the post-docs
who would be needed to staff the many newly formed research institutes in the
area. Therefore, the government has initiated programs to incentivize and sponsor
Singaporeans to pursue science education through A*STAR scholarships. Also,
foreign research scientists who have excelled in their respective fields are being
recruited to provide leadership and guidance within the cluster, enabling those in
the local area to train under them, and this provides another incentive for young
adults in Singapore to pursue education and employment in a science-related
field. While such measures may work in the long term, as PhD studies do take a
few years, short term needs still exist.
Another point regarding human capital that was brought forth in the
interviews was the lack of management expertise within the Singapore workforce.
Again, for this skillset many foreign business executives are being recruited, and
attractive financial packages are offered.
Training opportunities: 50% of respondents in San Diego (N=8) indicated they
provide training for their employees, and only one person (13%) reported that
incentives from the government existed to do so. In comparison, I observe the
direct effect of the role the Singaporean government plays in this regard, with
100% of Singapore respondents (N=7) offering training to their employees, 71%
of which are incentivized to do so. Anecdotally, the training opportunities for
those in Singapore target development of management skills as well as scientific
skills through forums, speaker series and courses offered at both local and
international universities. In a comparison between Singapore and San Diego, the
difference in the percentage of individuals who provide local training for their
employees was not statistically significant.
* Retention of talent: Turnover rates for both clusters were very similar, with 9% in
San Diego (N=16) and Singapore reporting 8% (N=8). When viewed by
stakeholder group, a significant difference was not seen.ttttt
Of more interest, however, is the percentage of turnover that remained
within the cluster, as this speaks to the synergistic effect of "cluster membership"
and indicates the ability of the cluster to continue to provide opportunities for
those skilled in this industry. It was useful to examine the data from both the
individual biocluster perspective, as well as that of each stakeholder group.
For those who reported a turnover rate greater than 0%, N=l 1 in San
Diego, 55% indicated that talent remained in the cluster. Singapore, with N=8,
reported 75% remained in the cluster. This difference amongst talent retention
rates between bioclusters was not statistically significant.S8$ When aggregated
by stakeholder group, across bioclusters, academia reported the lowest value at
38% (N=4), industry had 65%(N=13), and finance showed 100% (N=2), of
turnover remaining within the cluster. These values were also tested against each
other for trends of statistical significance, and none was observed.4' 444
Z-test for proportions, p-value=0. 11
* T-test for equality of means, p-value=0.724
Z-test for proportions, p-value=0.681
S"~Z-test for proportions: Academia vs. Industry, p-value=0.705
Z-test for proportions: Academia vs. Finance, p-value=0.548
Z-test for proportions: Industry vs. Finance, p-value=0.864
This data on retention of talent within the cluster can be combined with
that regarding the recruitment of talent within the cluster, to assess whether any
trends are present, as seen in the following graph:
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On a stakeholder group level, I observe a similar trend, as noted in the table below:
I therefore observe that a higher percentage of locally hired individuals leads to a
higher percentage of turnover that remains within the cluster.
For the data presented in this graph, the number of respondents were as follows: San Diego, local
hiring rate of 33% (N=15), percent remaining in cluster of 55% (N=l 1). Singapore, local hiring rate
of 72% (N=9), percent remaining in cluster of 75% (N=8).
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Part 3: Infrastructure
* Economic and public policies that enable or serve as barriers to collaboration: As
highlighted in the historical background section for the Singapore biocluster, the
government has led the effort in this regard. While there are no specific policies
that serve to enable collaboration, there are incentives to work with others on
research projects, as evidenced by applications for research funding, which
specifically ask if a proposed project will: 1) build the human capital and talent
pool within Singapore, 2) create intellectual property, and 3) include an industry
or research partner. This is a visible attempt by the government to promote
collaboration within the biocluster. In San Diego, policies of this nature were not
mentioned, as the government has almost no involvement in this area.
* Formal structures for collaboration: Individuals in both clusters were active
participants in networking and speaker events, San Diego with 81% participation
(N=16) and Singapore with 89% (N=9). However, anecdotally, the presence of
BIOCOM was mentioned by every one of the San Diego interviewees, and
seemed to be a backbone of the cluster, holding much political power. In
Singapore, while forums for networking (such as Bio-Singapore) do exist, they
are not well-developed and individuals mentioned that they wish there were more
formal structures for collaboration and networking provided by the cluster.
If I examine the participation by stakeholder group across the clusters, I
observe that industry had the lowest participation at 75% (N=12) and finance had
the highest participation at 100% (N=5), the difference of which did not prove to
be statistically significant.tttttt Also, while academia and industry had similar
levels of satisfaction from attending these events, finance seemed to find them
most valuable with a 90% satisfaction rating (N=5).
Intellectual property protocols: While this has already been well understood in
the San Diego biocluster, given that it follows standard US procedures for
patenting, it was interesting to hear about the way in which the companies in
Singapore approach this process. Most entities mentioned they typically file their
intellectual property in at least two of the following three countries: US, UK, and
Singapore. The US and UK focus is a result of their identification as target
markets, being two of the largest in this industry, and therefore recognizes the
need to focus attention on making sure that patents were registered locally in
order to sell in these countries. In Singapore, 100% of the eight respondents
indicated there were formal protocols for patents and licensing and they assigned
the accessibility of these protocols to their employees at a value of 6.8 on a scale
from one [low] to seven [high].
Also of interest was the fact the Singapore regulatory bodies kept a close
watch on the US FDA guidelines and typically followed its lead, incorporating
changes that the FDA mandated for the US into the Singaporean regulatory
guidelines.
Part 4: Cluster Culture
* Dominating culture: In both locations, there seemed to be specific fields that set
the tone for the biocluster culture. Note that more than one answer was allowed
for the following question.: "What would you say is the dominating culture in the
...... Z-test for proportions, p-value=0.593
cluster?" In San Diego, most of the eighteen respondents characterized the
culture as being strongly entrepreneurial, with many startup and early stage
companies (72%). Half the respondents also mentioned that a strong basic
research culture existed.
In Singapore, there was a mention of two mini clusters, namely
manufacturing and basic research. Most did not feel that the manufacturing area
counted as part of the "cluster" and therefore felt that basic research was the
dominating culture (75%, N=16). Also mentioned was the general feeling that
there should be a pursuit of functions and products within the life sciences
industry that will bring in revenues in any way for the cluster (18.7%, N=16).
This was an interesting point, and helps to explain the overall strategy within
Singapore, specifically the way in which investments are being targeted along the
product lifecycle.
* Cluster five-year outlook: In San Diego, of the eighteen respondents to this
question 67% indicated that positive growth is expected over the next five years,
and 22% expected that there would be no growth or perhaps a downturn in the
growth of the cluster. In Singapore, 100% of the twelve respondents believed
there would be a positive growth rate. However, almost all indicated that they did
not expect this growth to come from the basic research part of the cluster, as
products would not be far enough along in a five-year timeframe to bring in
revenues. This growth would mostly be from manufacturing.
* Disclosure of sensitive information: This question was designed to understand the
level of cluster competitiveness, by asking how worried individuals were about
disclosing sensitive information to others within the cluster. On a scale from one
[low] to seven [high], the fourteen respondents from San Diego averaged a 5.4,
and eleven respondents from Singapore indicated an average of 3.5. This marked
difference, statistically significant (p-value=0.0266), reveals that there is a general
feeling of competition and the need to "remain careful" of what you discuss and
with whom within the San Diego biocluster.
Anecdotally, San Diego interviewees mentioned that it was a very close-
knit, sometimes incestuous-feeling cluster in which one had to be careful about
who they are seen meeting with, as rumors easily will spread regarding possible
deals or joint endeavors when two parties are seen talking. There is a lot of
intertwining of people, and therefore one is often more cautious about the
disclosure of sensitive information. Also, for those outside of the "inner circle" of
successful serial entrepreneurs, as it was described, the cluster is perceived as
very competitive and not collaborative at all.
On a stakeholder level, as would be expected, finance was the most
worried about secrecy of its dealings (average rating of 6.5, N=3), and academia,
the least worried (rating of 4.1, N=7). Industry fell in between with an average
rating of 4.6 (N=14). However, the difference in average ratings between finance
and academia, and also between finance and industry, were not statistically
significant. ÷+-r
Knowledge spillovers: 67% of the respondents in San Diego (N=9) indicated that
they observed knowledge spillovers from the collaborations they were involved
" T-test for equality of means, Finance vs. Academia, p-value=0. 1214
T-test for equality of means, Finance vs. Industry, p-value=0.2027
in, a sentiment that was echoed in Singapore, with 63% of the eight respondents
feeling the same. Aggregated by stakeholder group, across bioclusters, I observe
this number rises to 100% in academia (N=4), drops to 56% for industry (N=9),
and to 50% for finance (N=4). This is in line with what one would expect given
the data thus far, indicating that academia has a tendency to engage in less formal
collaborations and reports a lower use of performance metrics. Perhaps the
exploratory nature of basic research collaborations, approached in a less
structured manner, allows for a higher occurrence of knowledge spillovers. Also
cited anecdotally amongst the aggregated seventeen respondents was the
increased frequency of knowledge spillovers that occur when engaged in
collaborations that include both academia and industry stakeholder groups.
Open-ended questions
By design, the open-ended questions provide a useful summary point as they directly
address the key goals of the study, namely the identification of the barriers and enablers
to collaboration within each biocluster and a comparison of the relative collaborative
environments of the two clusters of San Diego and Singapore.
Enablers for collaboration: The enablers highlighted for each cluster speak well
to their stages of development. In San Diego, the creation of products and
therapies is the current focus, while in Singapore, the development of basic
research and human capital is the primary goal. The Biopolis in Singapore is a
true enabler, as it allows for co-location of public and private entities in a space
where shared facilities are also available. While not directly co-located in this
manner in San Diego, most companies and research institutes are still near one
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another in the town of La Jolla, as highlighted in the historical background
section. In both cases, therefore, I observe the importance of proximity as an
enabler for collaboration.
Barriers for collaboration: The barriers identified for each cluster are analyzed,
followed by a comparison of the two clusters.
Anecdotally, San Diego had few collaborative endeavors between
companies within industry, with most occurring between industry and academia,
or finance and industry. The lack of company-company collaborations speaks to
the competition within the region and the issues of conflict of interest highlighted
above. The need for investment capital was very high, with many entrepreneurs
indicating that it was difficult to secure funding and that to remain afloat as a
company they often had to appeal to the venture capital firms in other, larger
locations, such as San Francisco and Boston. BIOCOM has been making efforts
to attract venture capital investment to the region by creating office space for VC
firms to have satellite offices locally and hosting many events in the area. The
San Diego Venture Group (SDVG), another trade association, has also been
making strides towards building a stronger base of investors in the region. Other
barriers to collaboration were the lack of large company presence, which many
believed would be a source of numerous joint endeavors within the industry, and
the limited time and availability of the overwhelming number of entrepreneurs to
pursue partnerships.
In Singapore, the issue of intellectual property and technology transfer
processes was highlighted by the majority as being a major barrier to
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collaboration. Specifically cited were the lengthy duration and poor deal terms
given to those who choose to work with the government-run A*STAR research
institutes. So while the government in some ways serves as an enabler to the
cluster, by providing a focal point of leadership, it also serves as a barrier to
collaboration in this case.
There was a general sense in this cluster that a political divide exists
between the older, established basic research entities (namely the universities of
Singapore, NUS and NTU) and the newer basic research institutes (six in number)
formed by the governmental agency, A*STAR. As described in the historical
background section, these two basic research "mini clusters" fall under different
ministries within the government, the first under the Ministry of Education and
the latter under the Ministry of Trade and Commerce. Therefore, they are divided
by design and it is difficult to integrate between them. A similar political divide
was mentioned to exist between the clinical side of the cluster (namely the two
Singapore hospitals, NUH and SGH), which falls under the Ministry of Health,
and the basic research side of the cluster. Collaboration between these two parties
is crucial for the genesis of new products with clinical applications, and the lack
of communication highlights another hindrance to the production of collaborative
innovation within the cluster.
To compare and contrast the two clusters, I believe it is helpful to note the
structures they inherently represent, one being bottoms-up and the other top-
down. In San Diego, the entrepreneurial drive that pervades the culture is an
effective enabler for collaboration. Entrepreneurs, by nature, are resourceful in
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finding what they need to get the job done, and this in and of itself promotes
collaboration. The existence of capitalism, creating a healthy level of competition
amongst the entrepreneurs, drives them to find a way to succeed. If this means
working with others, then that is what they do, as there is no other way to achieve
what they need to get their product or therapy to market or to secure funding by
venture capitalists. Therefore, perhaps the best way to characterize the San Diego
biocluster is a "bottoms-up" structure, in which one has to remain competitive in
order to survive and succeed. Risky endeavors are pursued as the potential
reward is high, and this is what enables potential collaborators to work together:
the acceptance and willingness to take risk.
In contrast, the Singapore government is a key enabler for the cluster
providing funding and leadership to many endeavors. This can be characterized
as a "top-down" structure, in which participants interact with the government in a
hub-and-spoke model, with the government as the central point. This is necessary
for the cluster while in the embryonic state of development. However, in order
for the cluster to remain competitive on a global level, it will need to somehow
create a culture of healthy competition and acceptance for risk. This is what
promotes innovation in the longer term, and is currently lacking in the cluster.
The natural risk-averse mentality of Singapore is shown in the endeavors it
chooses to undertake in this industry, namely manufacturing, outsourcing of
clinical trials, and various service functions, all of which are fairly safe in nature.
The government will need to send a strong message or somehow provide
incentives to the cluster members to increase their appetite of risk. The question
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really is whether the individuals have the ability to think like entrepreneurs, or
have they inherently become so accustomed to safer endeavors that they now have
an aversion to risk as well.
* Rating of collaborative environment: When asked to rate the collaborative
environment on a scale from one [low] to seven [high], the eighteen San Diego
interviewees indicated an average of 4.9, and the 16 Singapore respondents
indicated an average of 4.8. While seemingly very similar, it is interesting to note
the distribution and range of responses, as they tell a different story. In San
Diego, the range was full spectrum (one to seven) while Singapore showed a
smaller standard deviation, as responses ranged from three to six. When viewing
the responses within San Diego by stakeholder group, I observe the source of the
low-end responses as being from academia and industry (total N=13). This
reinforces the notion that there exists a competitive culture in San Diego, perhaps
seen mostly by entrepreneurs (N=8 for industry) and those in academia (N=5)
who are actively involved in startups. The average was countered on the high end
in San Diego by the larger industry players and the finance and trade association
interviews.
Responses between stakeholder groups, across bioclusters, were tested to
analyze whether trends existed. The difference in responses of finance and
industry were trending towards significance, while those amongst the other
stakeholder groups were not statistically significant."""""
§§§... T-test for equality of means, Finance vs. Industry, p-value=0.083
T-test for equality of means, Industry vs. Academia, p-value=0.4199
T-test for equality of means, Academia vs. Finance, p-value=0.2857
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* Definition of biocluster: Another question asked in this section, more so a part of
the introduction to the study, was whether the interviewees agreed with the
definition of the term biocluster which I had laid out. In Singapore, all of the
participants agreed (N= 16), as the definition and pictorial representation was very
similar to the one used by the Singapore government and those in the local
cluster. However in San Diego, a few of the respondents suggested that it should
be represented as a feedback loop, thereby showing the collaborations that occur
between clinicians and the earlier part of the development lifecycle, often leading
to products with high clinical use potential. This was noted as a good
modification for the future studies moving forward.
Assessment of Results from Relative Scoring Tools
In order to effectively compare the interview data between San Diego and
Singapore, I believe it is informative to utilize the relative scoring tools I defined earlier.
This enables me to make an objective comparison between the bioclusters, and allows for
a combination of factors to be analyzed at the same time.
Collaboration Scoring Model
The interpretation of the Collaboration Scoring Model is fairly straightforward as
it is simply a combination of relevant numerical responses from the data collected in the
questionnaire. The difference is that the questionnaire was wider in breadth, including
queries such as those regarding the interviewee's preferences for collaboration structure
and collaborator selection process. The Collaboration Scoring Model enabled me to
focus solely on the factors most important to determining how collaborative the cluster
was overall. Singapore proved to be more collaborative with a score of 29.3, as
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compared to 22.0 for San Diego, of a total of 49 possible points. When tested for
equality of means, this proved to be a statistically significant difference (p=0.0421) in
Collaboration Scores. The key contributors to the difference in scores, as was seen on the
scorecard shown in the Results section, were the high competitiveness within the San
Diego biocluster and the high retention of turnover within the cluster in Singapore.
The Collaboration Scoring Model was also used to assess the relative level of
collaboration in each of the stakeholder groups. In order for the tool to be used for this
purpose, the first section, namely environment for collaboration, was removed from the
analysis, as it would be an exogenous factor in this case and should therefore not be
considered. After running two scenarios, the first including data from those who
responded to all five questions asked, and the second including data from those
responding to at least three of the questions, I found a statistically significant difference
in Collaboration Scores between finance and industry. This was found to be true in both
scenarios tested (first scenario p-value=0.0189, second scenario p-value=0.0172).
In the second scenario, a statistically significant difference in scores was also
found when comparing academia and industry (p-value=0.0228). In both scenarios,
finance had the highest Collaboration Score, followed next by academia, and industry had
the lowest score. This data allows me to make an interesting observation: Industry,
which many would assume to be the source of collaborations within a cluster, is in fact
the least collaborative of all stakeholder groups.
Formality ofApproach Scores
The Formality of Approach scores facilitate an objective comparison between
bioclusters on the use of goals and metrics in collaborative endeavors and the method by
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which a collaborator is chosen. Here I find that San Diego had a higher score, with 12.6
of a possible 21.0 points, as compared to 12.0 for Singapore, a result that was trending
towards significance. Therefore, I observe that San Diego is perhaps more formal in its
approach to collaborations than are the biocluster participants in Singapore. However, it
is important to note that in both cases, the bioclusters only received approximately 60%
(12/21) of possible points.
Given the small spread in the scores, I decided to delve into the data further by
analyzing on a stakeholder level. As I discussed earlier in this section, I observe a
general trend in the interview data which suggested that the financial entities were more
formal in their approach to collaborations. I therefore wanted to verify the accuracy of
the Formality of Approach tool by testing whether it would result in the same general
findings. When the data was aggregated across bioclusters and viewed on the stakeholder
level, I find that indeed the financial firms had a higher score, at 16.3 points, as compared
to academia and industry, which scored 11.5 and 11.2 points, respectively. The
difference between the scores of finance and academia were statistically significant (p-
value=0.0479) and that between finance and industry was trending towards significance.
This supports the notion that the finance stakeholder group does in fact have a more
formal approach by which it engages in collaborative endeavors. In interpreting these
scores, it is interesting to note that a majority of the difference seen is a result of the
preference of finance to engage in a formal collaborator selection process, as indicated by
83% of respondents to this interview question. In comparison, 40% of industry and 25%
of academia reported a formal process.
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When further dissecting the data, on the biocluster stakeholder level, I did not
observe statistically significant differences amongst Formality of Approach scores, as
reported in the Results section.
Another analysis tool I used to understand the way in which collaborations are
approached and measured can be seen in Figure 16. This Venn diagram provides an
alternative view of the same information used to inform the Formality of Approach
Scores, while also showing an additional level of detail. In Figure 16, I observe the
aggregate responses to these interview questions (N=29) across both bioclusters, in which
only 19% of respondents reported using a formal collaborator selection process and
delineation of performance metrics and goals.
Formality of Approach Diagram (Aggregate, N=29)
Figure 16. Aggregated across both bioclusters, this diagram enables a view of combinations of the
interview questions. For those who responded to all three of these queries (N=29), we can see that 19%
utilized goals and performance metrics in their collaborations and had a formal selection process when
choosing their collaborative partner.
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This same diagram provides an interesting perspective when viewing the data from San
Diego and Singapore independently. Figure 17 shows the results from San Diego, where
the number of respondents to these queries was N=17. I find that 41.2% of those
interviewed used both goals and performance metrics, 20.6% used performance metrics
and had a formal collaborator selection process, 44.1% used goals and had a formal
selection process, while 20.6% of the respondents indicated they do all three.
Formality of Approach Diagram (San Diego, N=17)
Figure 17. This diagram shows that 20.6% of the 17 San Diego respondents affirmed the use of all three
methodologies queried.
In a similar manner, I can view the data from Singapore, where twelve of the
interviewees responded to these questions. Figure 18 shows their results, in which I find
that 12.5% of the twelve individuals interviewed approach their collaborations in a
formal manner while also using both goals and performance metrics.
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Formality of Approach Diagram (Singapore, N=12)
Figure 18. Singapore interview data from 12 respondents is shown above, in which we see that 12.5% of
individuals utilize measurement techniques for their collaborative endeavors and engage in a formal
selection process.
These diagrams provide an informative perspective of multiple combinations of
the interview questions, and a view of the behavior patterns seen in the two bioclusters.
However, they do not provide an objective relative comparison of the formality of
approach to collaborative endeavors amongst the clusters, and this is the reason that the
aforementioned tool, namely the Formality of Approach Score, was also developed.
Limitations of Data and Relative Scoring Tools
There are several limitations to the interview data presented that should be noted.
First, there is the issue of small sample size, with a total of 34 individuals interviewed for
this study. However, this is a large enough sample by which to observe if any trends, in
the way in which individuals collaborate and whom they choose to collaborate with, do in
fact exist. It allows one to take a preliminary look at whether there are any statistically
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significant differences, although the power to detect them is limited by the small sample
size. Most importantly, it is a large enough sample by which to characterize the key
enablers and barriers within the individual clusters. It also serves as a basis for future
work, as there has not yet been a study of this nature which takes an in-depth look at the
Singapore biocluster and compares it to US-based cluster, as I have done here.
Another limitation of the data is the issue of confidentiality and the
understandable hesitation on behalf of some participants, particularly within the
Singapore biocluster, to provide their views on the questions asked. While most felt
comfortable and were willing to provide the data, it should be noted that the views
provided were done so in a personal capacity and do not represent the views of the
institutions with whom the individuals are affiliated.
Regarding the scoring models that were developed to analyze and interpret the
data, one limitation is that they are informed by different sample sizes from each group.
While scores were normalized to reflect this, it is something that should be noted. Also,
all model inputs were given an equal weight in the determination of the final score, as
described in the methodology section. Therefore, the models assume a base case scenario
and do not account for the fact that any one factor input may in fact have a higher bearing
on the resulting Collaboration or Formality of Approach scores. However, the resulting
benefit of this simple model design is the ease by which such scorecards can be replicated
for other bioclusters, if one should so desire.
Challenges of Performing Study
Interviewee selection proved to be the most difficult element in the study process,
as identification of interviewees who would be able to provide informed perspectives was
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crucial in ensuring the value of the resulting data. The most useful sources of interview
contacts came from personal and professional networks, including the MIT and HST
alumni networks, the Singapore Economic Development Board, and connections via
Boston-based venture capital firms. Also interviewees were often able to connect me
with others in the area who might have valuable input for this study. Typical interviews
were obtained at the 3 rd or 4 th degree of contact, which required a great number of emails
and phone conversations to set up.
Suggestions for Future Work in this Area
This study has provided the necessary groundwork for characterization of
collaborative endeavors within the clusters of San Diego and Singapore. Using this
information, one can now delve into specific aspects of the methods of collaboration to
begin building a best practice model. Many interesting points and trends were brought
out via this study, and any single one of those, in and of itself, could be the topic for
another in-depth study. Also, many sub analyses are possible, such as whether those who
indicated they were worried about disclosure of sensitive information to others in the
cluster (measure of competitiveness) are correlated to an overall view of the collaborative
environment within the cluster. Another example would be to assess whether those who
use interest as a decision point for entering into a collaborative endeavor tend to enter
into more local collaborations, or whether this is correlated to the type of collaboration
(bilateral vs. multilateral) in which they engage.
One other way in which these two clusters can be further studied is via a
comparison of funding efficiency. By creating an input-output model, one could quantify
how efficient the use of funding is in each area, looking at seed or initial funding for
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collaborative endeavors and comparing it to revenue produced by the same. However,
this would only be possible when Singapore is at a stage where it has become able to
commercialize and produce products that return revenues to the cluster.
Lastly, while this study has focused on collaborations within clusters, it might be
of interest to understand the way in which different clusters work together to promote
their respective economic growth and enhance their productivity. This concept, the study
of collaborations between bioclusters, could also examine the effect that outsourcing has
on internal cluster collaborations and general productivity.
Conclusion
The initial goal of this thesis project was to characterize the enablers of and
barriers to effective collaboration within the bioclusters of San Diego and Singapore, and
then to empirically assess three hypotheses. I will address each of these separately in this
section.
After an extensive literature review, the design of a detailed questionnaire,
completion of 34 interviews across the San Diego and Singapore bioclusters, visits to
each of these areas, and an analysis of the resulting data, I can offer informed answers to
the questions initially set forth in this study.
Taking all these aspects into consideration, I summarize the key enablers of
collaboration within the San Diego biocluster as follows:
* The entrepreneurial mindset of the cluster participants promotes joint
endeavors.
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* The proximity to well-established and world-renowned research institutions
who actively engage in collaborative endeavors is an attraction for those in
the field and is a significant enabler.
* The efforts on behalf of trade associations in providing valuable networking
sessions and scientific forums for cluster participants are important for cluster
collaborations.
The key barriers for the San Diego biocluster are as follows:
* There is a lack of investment capital in the region, hindering those reliant
upon external investment from moving forward with collaborative endeavors.
* The limited time and availability amongst the many entrepreneurs leads to
decreased emphasis placed on working together unless absolutely needed.
* There is a competitive feeling within the cluster and this promotes secrecy and
isolation for some, especially those who are not part of the "inner circle" of
successful serial entrepreneurs. This point was further supported by a
significantly higher degree of cluster competition when compared to
Singapore (p-value=0.0266).
I highlight the key enablers for the Singapore biocluster as follows:
* The Singaporean government provides leadership and funding for the cluster,
enabling collaboration amongst the public and private cluster participants.
* Co-location of those in the life sciences industry, at the Science Parks and
Biopolis, as well as shared facilities provided to companies within the
Biopolis, facilitate collaboration.
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* The "pro-Singapore" mentality is a unifying factor, thereby promoting support
of other cluster members in collaborative endeavors.
The barriers for the Singapore biocluster are as follows:
* There is an aversion to risk that exists as a general mindset throughout the
cluster and this hinders the genesis of new and innovative collaborations.
* There are very few entrepreneurs in the area, who are the backbone of creating
an informal networking structure and initiating collaborative endeavors within
the cluster.
* A funding gap exists, that of mid-stage capital, and therefore companies
cannot progress beyond a certain point. The governmental entities focus on
funding both early and very late-stage companies, however the mid-stage
capital does not exist. Development of a more robust funding community is
hindered by the already large presence of governmental funding entities, as
well as the relatively few startup companies in the area, making it a less
attractive market for venture capital firms to enter.
Discussion of Hypotheses
I will now address evidence I have obtained regarding the specific hypotheses about the
collaborative environment within each of these clusters, the first of which was as follows:
* The lack of institutional barriers in Singapore, given the strong governmental
presence through funding and leadership of the biocluster, is an enabler for
collaboration. This results in a higher percentage of local collaborations for
Singapore, when compared to San Diego, and a more collegial and collaborative
environment.
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In fact there are two parts to this hypothesis, the first highlighting the Singaporean
government as an enabler for collaboration, and the second predicting that the Singapore
biocluster offers a more collaborative environment. I found that the first part of this
statement is only partially true, as the government serves as both an enabler of and a
barrier to the cluster. I find evidence in support of the second half of the hypothesis, as
indicated by the Collaboration Scoring Model developed specifically to analyze this
point.
Quantitatively, Singapore had a higher Collaboration Score, indicating that it
harbors a more collaborative and collegial environment, in comparison to San Diego.
Singapore scored a total of 29.3 of 49 possible points, while San Diego scored 22.0, with
the difference being statistically significant (p-value=0.0421). The model took into
consideration all the aspects mentioned here, namely the percentage of local
collaborations, the competitiveness within the cluster, and the rating assigned for the
collegiality of the environment by the interviewee. In addition, the model took into
account the percentage of time spent working with others locally, the participation of
interviewees in local networking events, the percentage of local hires, and lastly the
percentage of turnover remaining within the cluster. All these factors, in aggregate, help
to objectively determine the health of the collaborative environment.
However, for the first part of the hypothesis, quantitative data do not suffice.
There is an element that quantitative analysis will not show, simply that the culture
needed to promote innovation is not present in Singapore. While the government does
provide leadership and funding to the cluster, it also sets the tone for the culture by its
strong presence. This is important for initial formation and growth of the cluster, but
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does not result in it being an enabler for collaboration, and instead becomes a barrier in
the long term. The culture is risk averse, with "safe" endeavors in the life sciences being
pursued. This includes manufacturing, clinical trials, and other support functions which
are predictable and not risky in nature. Therefore, while one would assume that the
government support enables collaboration, which is the case through its policies and
funding, it also serves as a barrier by creating the culture of risk aversion.
Another way in which the government serves as a barrier to collaboration is
through intellectual property, i.e. patenting and licensing processes, which 53% of the
sixteen respondents indicated was an issue. Specifically cited were lengthy wait times
and restrictive deal terms. This further supports the notion that while the government
enables collaboration initially through its leadership, direction and support, as the cluster
slowly matures the government is in fact instituting barriers by the hub-and-spoke model
it has created.
An additional analysis performed on the stakeholder level, aggregated across
bioclusters, provided an informative result with regards to Collaboration Scores. Here I
observed that, of the three stakeholder groups analyzed, industry is actually the least
collaborative, and finance the most collaborative. In both the base and modified case
models, the base including only those who responded to all five of the questions, and the
modified version including those who responded to at least three of the five questions, the
difference in Collaboration Scores between industry and finance was found to be
statistically significant (base case p-value=0.0189, modified case p-value=0.0172). The
score for academia was found to be in between, with a statistically significant difference
from the industry score found in the second scenario (modified case p-value=0.0228).
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Therefore, for those cities and countries that are actively recruiting industry firms to join
their biocluster, it should be noted that the presence of industry may not increase local
collaborations. This may in part be due to issues of confidentiality and the natural effect
of competition. While industry does offer many other economic benefits to the
immediate surrounding area, it is in fact the least collaborative group within the
biocluster.
The second hypothesis regarded cluster structure, and was as follows:
The differences in cluster structure, namely organized (top-down) for Singapore
and organic (bottoms-up) for San Diego, is a clear distinction that will be
reflected in the increased formality of process by which collaborative endeavors
are engaged in Singapore.
There was little support for this hypothesis, as shown via Formality of Approach
scorecards, developed to interpret the interview data in a manner that allows for analysis
of this hypothesis. San Diego had a Formality of Approach Score of 12.6, as compared
to 12.0 for Singapore, of a possible 21 points. A test of this difference resulted in an
indication of trending toward significance. Taken into account were three key factors,
namely the selection process used when choosing a collaborator, the use of goals in
collaboration, and the delineation of performance metrics in their collaborative
endeavors. Another point which supports this absence of increased formality in
Singapore is found by simply looking at the way in which those in the Singapore
biocluster choose their collaborators. Specifically, 32% of respondents in Singapore
reported a formal process, as compared to 50% in San Diego. While this is not what I
expected to observe, given the top-down structure present in the Singapore biocluster, I
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believe that the relative infancy of the cluster likely plays a role in formality of approach
to collaborations. In addition, the high percentage of basic research collaborations which
are undertaken in the region likely contributes to this, as the interview results also
revealed that the academia stakeholder group has the least formal approach to
collaborative endeavors. Therefore, if most collaborations in the Singapore biocluster are
within academia, then it naturally follows that they will be more informal in structure.
Also, on a stakeholder level, this study finds that financial entities are in fact more
formal in their approach to collaborations, as seen via the high Formality of Approach
score of 16.3 of a possible 21 points. Industry and academia followed with scores of 11.5
and 11.2, respectively. The difference in scores between finance and academia proved to
be statistically significant (p-value=0.0479). From the fact that there are fewer financial
entities within the Singapore biocluster, given that the government provides a majority of
the funding, it logically follows that the Formality of Approach score for the cluster is
lower than that of San Diego.
The last hypothesis, regarding capital investment, was as follows:
Heavy capital investment, as seen in Singapore, is a necessary but not sufficient
enabler for the creation of a truly collaborative biocluster. I expected to find that
the abundance of funding in Singapore in fact has the opposite effect, becoming a
barrier by decreasing the need to collaborate.
This statement was strongly supported by the anecdotal evidence in the interviews
conducted for this study. Many said that collaboration first requires the identification of
a specific gap or need, and then one sets out to fill this need by looking for an appropriate
collaborative partner. As funding is available in the Singapore cluster via the
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government, this identified need is often one of subject matter expertise, and that is
therefore what drives collaboration.
This hypothesis is supported by the data presented, which documents that the top
quality that Singaporeans look for in a collaborator is subject matter expertise and
domain knowledge (53% of respondents indicated as such). In San Diego, a strong track
record and strategic fit for the project both took an equal share to expertise on the list of
desired qualities (each receiving 35% response). This is also supported by the dominant
culture of basic research within Singapore, as compared to one of entrepreneurialism and
startup companies in San Diego. Therefore, in Singapore the need to collaborate only
exists when one is in search for a specific expertise, while in San Diego there are many
reasons to seek a collaborator, one key reason being funding, as virtually nothing is
possible on your own. Thus, the overabundance of funding does in fact act as a barrier
for collaboration within Singapore.
In addition to the empirical assessment of hypotheses performed, trends in the
relative collaborative behavior of stakeholder groups were observed through this study.
Most notable was the high Formality of Approach and Collaboration Scores of the
finance group, and the low scores of each found in the industry group. Also, notable was
the significantly low percentage of local industry collaborations, as compared to
academia (p-value=0.0002). Lastly, in the recruitment of talent, it was found that
industry in Singapore was significantly more reliant upon the local cluster for human
capital than was industry in San Diego (p-value=0.0029).
Finally, an unintended byproduct of this study was the identification of a possible
model for the development of a biocluster. This was derived through the review of the
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respective histories of formation for San Diego and Singapore. While methods for
biocluster development still remain to be well-characterized, this comparison of clusters
does provide some similarities of interest. Starting with the foundation of basic research
and its resulting spinoffs through intellectual property and startup companies, next we
find the development of a key biotech firm which also has spinoffs, followed by
attraction of large pharmaceutical companies to the area. The local collaborations
provide the glue that holds the cluster together. This potential model for biocluster
development needs to be further explored and tested for applicability to other areas, but
does suggest a promising start.
In conclusion, the bioclusters of San Diego and Singapore are excellent examples
of extremely different structural environments, both focused on the same end goal: to
make significant advancements within the life sciences industry. Collaborations are
enablers of success, as they are vital to the cycle of innovation in this field, and are
needed to drive these scientific advancements forward. I conclude based on the data
presented that the co-location of life science entities in confined geographic areas, termed
bioclusters, do in fact enable success of their member firms, as they may have a positive
end effect of increasing productivity through effective collaborations.
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Appendix B: Ouestionnaire and Interview Design Guidance
Many thanks to the following individuals for their time and constructive feedback in
further refinement of the thesis questionnaire and interview process for the purposes of
this study.
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Ernst Berndt, Ph.D., MIT Sloan School of Management, Thesis Co-Supervisor
Dr. Gigi Hirsch, Center for Biomedical Innovation, Senior Advisor
David Weber, MIT Sloan of Management, Director of Corporate Relations
Lesa Mitchell, Ewing Marion Kauffman Foundation, Vice President, Advancing
Innovation Group
Bob Litan, Ewing Marion Kauffman Foundation
Tom Allen, Ph.D., MIT Sloan of Management, Operations Management Professor
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Sciences and Technology Degree Candidate
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Appendix C: Interviews Conducted
The time and participation on behalf of the individuals from the following organizations
was much appreciated. They provided the most crucial element of the study, and it was a
wonderful experience to meet so many individuals from around the world working
towards the advancement of science.
Please note, however, that views expressed in this study are not representative of the
organizations to which the interviewees are affiliated.
Amylin Pharmaceuticals, Inc.
Agency for Science, Technology and Research (A*STAR)
Becton Dickson
BIOCOM
Biogen IDEC
Bio*One Capital
BIO Singapore
BioMedical Research Council (BMRC)
BrainCells, Inc.
Ceregene, Inc.
Curexl, Inc.
ES Cell International
Forward Ventures
GlaxoSmithKline
Lilly-Singapore Center for Drug Discovery
Maccine, Inc.
Nanyang Technological University
National University of Singapore
Novartis
Osio Corporation
Proquest Investments
S*BIO Pte Ltd.
SAIC Life Sciences
Singapore Economic Development Board
Singapore Stem Cell Consortium
Southern California Biotechnology Center, Miramar College
Temasek Holdings
University of California San Diego, TechTIPS
University of California San Diego, von Liebig Center
University of California San Diego, Bioengineering Department
Vical, Inc.
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Appendix D: Additional Statistical Analyses Performed
In addition to the statistical analysis reported in the Discussion section, the following
regressions were also performed to test for statistically significant correlations amongst
interview data.
Aggregated Biocluster Analysis
Variable 1 Variable 2 P-Value Correlation
Coefficient
Rating of Rating of 0.9568 0.0114
collaborative competition within
environment (1-7) cluster (1-7)
Interest as a Formal collaborator 0.2837 0.2855
decision factor (%) selection process
Local hires (%) Turnover remaining 0.2229 0.3346
in cluster (%)
Interest as a Collaborations with 0.4405 0.2155
decision factor (%) breakthrough
potential (%)
Use of goals Use of performance 0.1334 0.2854
metrics
Rating of Local collaborations 0.3498 0.1801
collaborative engaged (%)
environment (1-7)
Local Rating of 0.6002 0.1127
collaborations competition within
engaged (%) cluster (1-7)
Local Collaborations with 0.7450 0.0685
collaborations breakthrough
engaged (%) potential (%)
Interest as a Knowledge 0.6414 0.1429
decision factor (%) spillovers in
collaborations (%)
Local Time spent working 0.0060 0.4982
collaborations with others in local
engaged (%) cluster (%)
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Aggregated Stakeholder Analysis
Stakeholder Variable 1 Variable 2 P-Value Correlation
Group Coefficient
Academia Local Time spent 0.6664 0.1819
collaborations working with
engaged (%) others in local
cluster (%)
Academia Local Bilateral 0.7991 0.1080
collaborations collaborations
engaged (%) engaged (%)
Industry Rating of Time spent 0.1461 0.3941
collaborative working with
environment (1-7) others in local
cluster (%)
Industry Use of goals Collaborations 0.8444 0.0605
with
breakthrough
potential (%)
Finance Local Time spent 0.1644 0.6476
collaborations working with
engaged (%) others in local
cluster (%)
Finance Rating of Local 0.8751 0.0835
collaborative collaborations
environment (1-7) engaged (%)
San Diego Data Analysis
Variable I Variable 2 P-Value Correlation
Coefficient
Rating of collaborative Local collaborations 0.4978 0.1766
environment (1-7) engaged (%)
Local collaborations Collaborations with 0.6056 0.1583
engaged (%) breakthrough
potential (%)
Rating of collaborative Rating of competition 0.8551 0.0538
environment (1-7) within cluster (1-7)
Use of goals Use of performance 0.2331 0.3055
metrics
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Singapore Data Analysis
Variable 1 Variable 2 P-Value Correlation
Coefficient
Rating of collaborative Rating of competition 0.2726 0.3630
environment (1-7) within cluster (1-7)
Local collaborations Time spent working 0.2287 0.3757
engaged (%) with others in local
cluster (%)
Bi-lateral Local collaborations 0.7369 0.1086
collaborations (%) engaged (%)
Interest as a decision Collaborations with 0.7827 0.1077
factor (%) breakthrough
potential (%)
Use of goals Use of performance 0.4241 0.2548
metrics
Participation in Local collaborations 0.3102 0.4121
networking events engaged (%)
Interest as a decision Formal collaborator 0.7623 0.1180
factor (%) selection process
Bi-lateral Collaborations with 0.9627 0.0152
collaborations (%) breakthrough
potential (%)
Local collaborations Formal collaborator 0.7100 0.1201
engaged (%) selection process
Local collaborations Rating of competition 0.8620 0.0633
engaged (%) within cluster (1-7)
Local collaborations Rating of 0.4913 0.2204
engaged (%) collaborative
environment (1-7)
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Appendix E: Interview Ouestionnaire Worksheet
Note: Questions in bold denote those that were consistently asked in each interview.
Remaining questions were asked depending on available time.
Name:
Date:
Biocluster:
Company:
Position:
Introduction
We are using the following definition of a biocluster (refer to powerpoint slide).
How do you participate in the biocluster?
Is this the way you would have described it?
How would you characterize the collaborative environment within the biocluster?
How would you rate the collaborative environment within the biocluster (on
a scale from 1 [low] to 7 [high])?
What is the impact the biocluster has had?
What are the top 3 enablers for effective collaboration within the biocluster
community? Why?
What are the top 3 barriers for effective collaboration within the biocluster
community? Why?
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Productivity
What types of collaborations are you engaged in? (e.g. basic research, co-author
papers, collaborative studies, manufacturing capabilities, etc.)
What percentage of these are bi-lateral vs. multi-lateral (%)?
What are the possible outcomes of such collaborations?
Academia: Is there a pro-publication bias?
Finance: What trends do you find in life science investments?
follow changes in the general economy?
Do they typically
Do you have specific goals and performance metrics for each of your
collaborations? If so, what are they?
Goals:
Perf Metrics:
How much of a role does interest in the technology play in your decision of
whether or not to engage in a collaboration (%)?
What are the criteria used to select a collaborator?
What are the criteria used to decide whether to continue working with them?
What are the criteria used to terminate a collaboration?
Is this a formal or informal process?
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Of the collaborations you are currently involved in:
What percentage have breakthrough potential in your mind (breakthrough =
novel in field) (%)?
What percentage is in the local biocluster (%)?
If external to local biocluster, are they in other bioclusters?
What is your perception of return on investment (ROI) on these
collaborations?
What percentage of your time is spent working with others in the local
biocluster?
Human Capital
Recruitment: What incentives are provided in the recruitment of talent?
What percentage of individuals that you hire are locally educated (%)?
Training: What kind of training is provided for the local workforce?
What training incentives are provided in the cluster (by government, industry)?
How available are such programs to your employees?
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What is the turnover rate (of your organization)?
Is the turnover within the cluster or do people leave for other areas?
Where do people go when they leave? Is it to an organization in the same
industry?
Retention: What incentives are provided to retain talent?
Are there policies in place for families and dual careers? Subsidized housing? Day
care?
Are there incentives to travel to external conferences/ professional meetings?
Infrastructure
What economic policies (e.g. tax credits, permits, facilities) and other public policies
are in place that are:
Enablers of collaboration?
Barriers to collaboration?
What formal structure(s) does the cluster provide for collaboration (e.g. group
purchasing policies, training, networking, job websites)?
Do you participate in and access them?
Do you find these valuable?
Are there policies in place that make hospitals accessible for research?
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Are there protocols in place for patents? Licensing?
Can you easily access them? On a scale from 1 [low] to 7 [high], rate them.
How are proceeds from licenses/patents divided amongst participants?
Whose name is on the patent?
Cluster Culture
What would you say is the dominating culture in the cluster (e.g. one of starting
companies, basic science research, other)?
How much economic growth (job creation, revenue generation) do you see in the
cluster in the next 5 years (%)?
Who are the most desired collaborative partners within the cluster?
How worried are you about disclosing sensitive information to others within the
biocluster (scale of 1 [low] to 7 [high])?
Are there knowledge spillovers from the collaborations you are involved in? If so, what
types of collaborations most often lead to knowledge spillovers?
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Appendix F Slide presentation used in interview process
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Q (:Center for Biomnidical Invation '  ::
Enhancing Productivity in
Collaborative Innovation
Rupa Bahri, Biomedical Enterprise Program
Thesis Advisors: Frank Douglas, Emst Bemdt
'hrii
Project Goals and Scope
* This study is a characterization of the barriers
and enablers of effective collaboration within a
biocluster. It will inform the eventual
development of a best practice model for
enhancing productivity through collaborative
innovation.
* Three bioclusters, namely Boston, San Diego,
and Singapore, were chosen due to:
* Varying longevity of cluster presence (mature vs. new)
* Differences in history of formation (spontaneous vs. planned).
I'ir~
..,.
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What is a Biocluster?
I
I
Support Functions
A cluster represents an entire value chain of a broadly defined
industry sector from suppliers to end products, including its related
suppliers and specialized infrastructure.1 All parties who support and
contribute to this value chain at any point in the process are
considered a part of the biocluster.
1America's Biotech and Life Sciences Clusters; Milken Institute, 2004
I'liir
An interview questionnaire has been designed to
understand the various aspects of cluster collaborations
and follows a specific format.
Introduction _ Pr I  Human ClusterSProject roductvity i nfrastructure Culture
Explanation of Characterize Recruitment and Economic and Future growth of
project goals types of retention of public policies cluster
collaborations talent
Definition of Structured Competition
biocluster Identify Training for local opportunities for within cluster
measurement & workforce collaboration
Understand selection criteria Dominating
interviewee's Turnover rate Patent and culture
role in bioduster Local vs. within cluster licensing
worldwide protocols Disclosure of
collaborations sensitive
information
I'Iir~
Interviews targeted at the following individuals will enable
us to better understand the extent of the collaborative
environment within each of the three bioclusters of interest.
Professors actively
involved in collaborative
efforts
Technology licensing
offices of universities
I> ndividuals involved with
establishing economic
and public policies that
affect biocluster
> Large companies
Head of Research, HR, BD
> Medium-sized companies
Head of Research
> Start-ups
CEO, COO
Financial Support
Venture capital firms
Angel investors
IIiri
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